2008 Annual Report - College of Pharmacy - The Ohio State University

WelcomeWe are pleased to present this annual report for the 2007-2008academic year. The exceptional accomplishments described here resultfrom our strong and robust academic, educational, research, andoutreach programs.In the 2007-2008 academic year, a total of 468 students were enrolledin our entry-level Doctor of Pharmacy (PharmD) program, and thenontraditional PharmD (NTPD) program had 86 students enrolled.Following graduation, the graduates accepted positions in communitypharmacy or ambulatory care practices, in hospital pharmacy practice,and in residencies to continue their education and specialization viapostgraduate opportunities. At the undergraduate level, the BS inPharmaceutical Sciences program graduated 103 students, the largest ata single commencement. Our graduate programs in the College ofPharmacy continue the tradition of excellence, with approximately 90students enrolled this fall in the areas of medicinal chemistry andpharmacognosy, pharmaceutics, pharmacology, and pharmaceuticaladministration. In 2007-08, 14 PhD degrees and 19 MS degrees wereawarded. The high quality and the maturity of our students extend wellDean Robert W. Brueggemeierbeyond their academic accomplishmentsin the classrooms. Involvementin student professional organizations, engagement in researchexperiences, and participation in national meetings are excellent opportunities for students to develop“outside” the classroom and to network with other students, faculty, and pharmacy colleagues from aroundthe nation.Faculty and students perform excellent disciplinary research and exciting interdisciplinary research indrug discovery, drug action, drug delivery, drug development, medication safety, and therapeutic outcomes.Faculty, PharmD students, and residents engage in training and delivery of therapeutic services in variousarea hospitals, clinics, ambulatory/community practice settings, and exciting innovative practice models ofmedication therapy management. Stimulating outreach and engagement activitiesby faculty, students, andstaff occur at the regional, national, and international levels. Our Alumni Society continues its outstandingwork to support the College’s students and faculty, and the advisory groups provide important feedback onthe College’s initiatives and directions. Our alumni preceptors mentor our pharmacy students throughclerkship rotations, internships, and participation in professional organizations. In 2007-08, manyaccomplishments and continued excellence have been attained by the alumni and friends of our College,and the breadth and depth of engagement in a wide variety of areas in pharmacy of greater than 6,300alumni of the College of Pharmacy are exceptional.The strong academic programs in professional, graduate, and undergraduate education and the excellentresearch and scholarship are a reflection of the high quality faculty, students, researchers and staff of theCollege. We celebrate many “Points of Buckeye Pride.” These include our PharmD program obtaining aranking of 5th in the 2008 US News & World Report, our PhD program obtaining the “high quality” ratingin the OSU Graduate School review in 2008, and a faculty productivity ranking of 2nd in Pharmacy in2007 by an independent organization. Our collective efforts maintain The Ohio State University Collegeof Pharmacy among the top pharmacy schools in the nation.This issue of our College annual reporthighlights this past year’s accomplishmentsand I hope you find the report to beinteresting and insightful.Sincerely,Robert W. Brueggemeier, Ph.D.Dean and Professor

Education and AcademicsDoctor of Pharmacy ProgramsThe outstanding academic programs in the College of Pharmacy experiencedcontinued growth and enhancement during the 2007-2008 academic year. Thesedegree programs include the graduate professional Doctor of Pharmacy (Pharm.D.)programs, the undergraduate B.S. in Pharmaceutical Sciences, and graduate M.S. andPh.D. programs.Entry-level PharmD (ELPD) – prepares students forpharmacist licensure, embracing a patient-focused mission. Threeyears of didactic course work covering principles of pharmaceutical,administrative and clinical sciences and some pharmacy practiceexperience, followed by a full year of full-time professionalexperience, complete the program.Non-Traditional Doctor of Pharmacy Program (NTPD) –distance learning program for BS prepared pharmacists leading toDoctor of Pharmacy degree. Having admitted our final class inJanuary 2007, our remaining students (66 as of June 2008) areworking on completing their courses and required rotations. Todate 98 non-traditional students have graduated from the program.This dedication and time commitment are equipping them to meetSylvan Frankthe clinical challenges of present and future pharmacy practice.Associate DeanPharmD/Master in Business Administration (PharmD/MBA)and the PharmD/Master in Public Health (PharmD/MPH) – Combined degreeprograms give students the opportunity to complete both degree requirementsin a shorter timeframe.Graduation in June saw 111 entry-levelPharmD students earn a Doctor ofPharmacy Degree (25 cum laude,17 magna cum laude and 4summa cum laude). Thesestudents have indicatedthat they are headed tocareers in communitypharmacy (62%),hospitals (15%),industry (2%), managedcare (2%) and otherdynamic pharmacy relatedfields, i.e., consulting,research and/or teaching (2%).Figure 1: Positions accepted by2008 PharmD Graduates2

A new class of bright, energetic pharmacy students came to campus Autumn2007 (126 PharmD students) to begin their journey to becoming our nextgeneration of pharmacists, well-prepared to meet the health-care challenges ofthe future. Coming from a recruitment class of 908 applications, our Autumn’07 entering class boasts a GPA of 3.54; an overall mean PCAT score at 84thpercentile and over 80% entering with a Bachelor’s degree.Together with these new students, our Entry-Level PharmD class counted159 of their number on the Dean’s Honor roll for the 2007-2008 academicyear; twenty-three were initiated into Rho Chi,the national Pharmacy Honor Society; andmany received individual and studentorganization awards at the university andnational levels.As in the past, our retention of studentsremains strong (97% since 2000) and ourgraduates continue to excel in the NAPLEXand MPJE examinations (98.9% and 100%first-attempt pass rate). We are pleased that ourstudent financial aid increased by 12.79% in2007. Scholarship support, a criticalHeather DetersDirector of Student Affairscomponent of financial aid, also increased thisyear and was celebrated at our 4th AnnualEndowed Scholarship Reception.We also admitted the seventh class of 25Early-Admissions Pathway students. Many of these students matriculate intothe PharmD Program, while others go on to complete the BSPS program.Because we value a diverse student population we continue to fosterrelationships with the institutions of the Atlanta University Center and theUniversity of Puerto Rico toward the goal of minority student recruitment.These efforts, combinedwith our outstanding,competitive reputation, arereflected in the 17.5%minority-presence studentsin the PharmD program.Brett Perlberg, PharmD StudentPresident of his pharmacy classand of Kappa Psi, Brett, a thirdyear PharmD student, clearly hasthe leadership qualitiesnecessary to succeed in anycareer path he chooses. On anAir Force scholarship at OSU,Brett may decide to make themilitary his profession. In anycase, he will take away importantlessons from his time here atOSU.Brett grew up in Michigan (butwe wont hold that against him!)and earned his undergraduatedegree in Zoology (MiamiUniversity). Now that he is atOSU he sees the difference that amajor research institution canmake in one’s education. “Thewhole state is behind OSU. It is apowerhouse in more than justfootball”, says Brett.Working at Krogers as anintern and on experientialrotations has reinforcedconcepts he is learning in theclassroom and the necessity ofclear communication skills. Heunderstands and values theinteraction between pharmacists,physicians and patients; the allimportanthealth team approach.In January this year Brett wascommissioned as 2nd Lieutenantin the United States Air Force andin 2010 will earn his Doctor ofPharmacy degree.3

Experiential education is critical to the comprehensive education of ourpharmacy students. The mentoring and teaching efforts of our educationalpartners is an immeasurable part of their education. We placed 350 studentsin 1,424 pharmacy practice experiences this past year. The distribution ofthese students is shown in Figure 2.Nnenna Anekwe, PharmDStudent – Born into a very largefamily (9 children) in Lagos,Nigeria, Nnenna (second-yearPharmD student) came to the US(Indiana), with her brother to livewith an uncle and complete highschool in 1998. Because manyfamily members were in themedical field and because ofNnenna’s interest and strength inscience and math, she was onthe path to medical school. Whilecompleting her BS in Chemistry atan Indiana community college,Nnenna had an opportunity towork at an uncle’s medical clinicwhere she discovered she foundthe pharmacy at the clinicinterested her more.By this time Nnenna’s familyhad emigrated to the US. ButNnenna was anxious to beindependent and make her ownway in life. It was this desire thatled her to apply to OSU.After completing her PharmDdegree, Nnenna plans to work ina patient-centered environment.Her rotations are telling Nnennathat this is the best fit for herpersonality. She found OSU awelcoming environment and hasbecome very involved in studentleadership activities. Nnenna is arepresentative on the PharmDCommittee, Vice President forSNAPhA and Secretary for PhiLambda Sigma.Figure 2. PharmD Professional Experience SitesShannon Hendricks PharmDStudent – Shannon, third-yearPharmD student, has always hadan interest in, and excelled in,science. But, when given thechance to work in a reallaboratory, discovered this wasnot her passion. She was meantto be a teacher. The journey tothis end has not been a straightline for Shannon.After a first year at CarnegieMellon, Shannon earned twodegrees, Electrical Engineeringand Chemistry, from Wright StateUniversity. She discovered that alink between science andteaching could be found in theprofession of Pharmacy andapplied here at Ohio State. Now,in her third year, she has foundher niche.Shannon looks forward to theday when she will be able toimprove patients’ lives bycounseling them on their healthissues and medication questions.In the meantime she enjoyshelping her classmates with theirschool work and volunteering hertime and efforts in the community.4

The experiential program is based on the philosophy and process ofpharmaceutical care; therefore, the program fosters the development of skillsrelated to the provision of direct patient care and medication therapymanagement, in the context of both dispensing and non-dispensing practicesites. In recognition of the importance of preceptors skilled in human and fiscalresources, we honored our valued preceptors this year:Excellence in Experiential Education Award (recognizing innovation, excellencein practice and teaching, excellent student evaluations and engaging students inpharmacy practice):❖ Kroger PharmacyPreceptor Mentors of the Year (Introductory Pharmacy Practice Experience):❖ Cynthia Hoffman, RPh, Kroger❖ Megan Roberts, RPh, Giant Eagle❖ Tom Wiley, RPh, CVSPreceptors of the Year (Advanced Pharmacy Practice Experience):❖ Elizabeth Kuschner, RPh, Progressive Medical Inc.❖ James McAuley, PharmD, Associate Professor ofPharmacy Practice & Neurology, OSU College ofPharmacy❖ Jennifer Rodis, PharmD, Assistant Professor –Clinical, OSU, College of Pharmacy❖ Jill Westbrook, PharmD, Giant EagleAt our Preceptor AppreciationBreakfast, June 2008, wepresented the Excellence inExperiential Education Award toBill Sheridan and Doug Cornelius(above), representatives of theKroger Company. Along withKristin Casper, Tara Green andKroger pharmacists, they wereinstrumental in forming apartnership between the KrogerCompany and the college toprovide new rotation sites forfourth-year PharmD students.One example is the Kroger PatientCare Center (KPCC). Studentsengaging in the KPCC areencouraged to think about howpharmacy practice may change inthe future and how we can workto secure the pharmacist's role asa vital member of the healthcareteam.This partnership opened thedoor for multiple opportunities towork on pilot projects and newactivities at many Kroger sitesthat can advance the professionof pharmacy and highlight theefforts of each partner.In addition to receiving theExcellence in ExperientialEducation Award, the AmericanAssociation of Colleges ofPharmacy presented the CrystalApple Award to the KrogerCompany in recognition of theircontributions to excellence inexperiential education.5

Doctor of Pharmacy Graduates (2007-2008)Name Hometown Honors AwardsAbouzaid, Safiya Rabat, Morocco Cum LaudeAhmed, UrejiColumbus, OHAllison, Cody LOdessa, TXBalase, Huglyn DSchaumburg, ILBar, Yulia BDnepropetrovsk, UkraineBarr, Erin DeniseFairborn, OHBendinelli, Linda A Columbus, OH Cum LaudeBilinovich, Deanna Lyn New Franklin, OHBlack, Christine A Milwaukee, WI Magna Cum LaudeBlaine, Marjorie Rose Seattle, WA Cum LaudeBlount, Anita MarieLouisville, KYBoakye-Dankwah Jr, James Dublin, OH Magna Cum Laude SNPHA AwardBradley, Nicholas AChassell, MIBrandle, Christopher E Cleveland, OH Cum LaudeBremer, Catherine Marie Granville,OH Cum Laude Phi Lambda SigmaLeadership AwardBromfield, Lisa Elaine Kingston, Jamaica Cum LaudeBrown, Megan Marie Morral, OHBuckley-Hall, Kimberly Ann Mentor, OH Magna Cum Laude Benjamin BalshoneStudent AwardBush, Erin CathleenDelafield, WIByrd, Jennifer Nicole Jackson Center, OHCasey, Jynel Ann Pickerington, OH Cum LaudeCerny, Christopher M Kirtland, OHCheung, Philip Wai-nang Hong Kong, ChinaChihara, Rika JuneCarmel, INChoi, Michelle Jung Flushing, NY Magna Cum Laude Merck AwardCieckiewicz, Anita AParma, OHClark, Laura Lynn Austintown, OH Roche PharmacyCommunications AwardCollins, Carol AnneDayton, OHDell'Omo, Jessica L Independence, OH George B. KauffmanAnnual Memorial AwardDigges, Jennifer Louise Belpre, OH Magna Cum LaudeDorozenski, Tia Denise Troy, MIDuchemin, Marcus Noel Salem, IN Cum LaudeEffinger, Steven Matthew Louisville, KYEndicott, Elizabeth Ashley Inez, KYEppley, Melody ASidney, OHEspinas, Sebastian Samson Dover, OHFan, Shuang Beijing, China Magna Cum LaudeFinnegan, William M Dublin, OH Cum LaudeGantt, Tracy CarleenSparta, OHGiallourakis, Ted George North Olmsted, OHGoodman, Jason Robert Tampa, FLGreenfield, Marcia Jeanne Marietta, OH Cum LaudeGregor, James Walter Celina, OH Cum LaudeGrillon, Brandon James Brewster, OHGronauer, Erin Jeanine Cincinnati, OHGuenther, Sara Jo Fairfield, OH Magna Cum LaudeHa, Yoosook LeeProctorville, OHHaile, Yonatan Merhu Oakland, CAHargrove, Bradley Steven Pickerington, OHHeinrichs, Melisa Josephine Cincinnati, OH Magna Cum Laude Merck Award6

Name Hometown Honors AwardsHenry, Carlese Yvette Nassau, BahamasHenshaw, Megan Ann Marietta, OHHenslee, Anneliesa Adele Medina, OHHermansen, Matthew D West Jordan, UTHernandez, Julie Anne Casa Grande, AZ Magna Cum LaudeHildebrand, April Jo New Philadelphia, OH Magna Cum Laude APHA-ASP Mortar & PestleProfessionalism Award/Faculty Award for the OutstandingGraduating Doctor of PharmacyStudent of the YearHimmeger, Larissa Marie Jackson Center, OHHirsch, Andrea Elizabeth Maumee, OH Cum Laude GlaxoSmithKline PatientCare AwardHopkins, Rachel KayReynoldsburg,OHHradesky, Jamie Ann Eastlake, OHInman, Kristin RMcConnelsville, OHJawara, Salimatou Dharan, Saudi Arabia/ Cum LaudeUnited KindgomKahl, Katharine Elizabeth Hartford, OH Cum Laude Anne L. Burns AwardKinkaid, Karah Jean Maumee, OH Cum LaudeKoon, Kelli Jo Marietta, OH Magna Cum LaudeKostelnick, Julia Elizabeth Wadsworth, OH Cum LaudeKramer, Jessica Nicole Kettering, OHKremeier, Jessica H Ruston, LA Magna Cum LaudeKuli, Lori Beth Dayton, OH Magna Cum LaudeKusick, Karissa Nicole Chicora, PA Cum Laude Stephen W. BirdwellStudent AwardLattanzio, Sara Lynn Boardman, OH Cum LaudeLau, Albert KahangNorthwood, OHLim, HannahEllicott City, MDLoy, Shelli A New Washington, OH Magna Cum LaudeLuca, Lynne Ann Cincinnati, OH Magna Cum LaudeMaciuleviciute, Evelina Bay Village, OHMayer, Jonathan S Hamilton, OH Magna Cum LaudeMazzamuto, Antonino Carlisle, PAMcKenzie, Cameon Antoinette Houston, TXCum LaudeMcKenzie, Marva AJamaicaMcKillip, Katie JoGahanna, OHMiller, Britannie Nichole Dublin, OHMiller, Marjorie Ann Perrysburg, OH Cum Laude Marvin & Geraldine GaegesMemorial AwardMolnar, Erinn Elizabeth Hilliard, OH Cum LaudeMoore, Jennifer Marie Alexandria, OHMori, Sherry Lynn Seven Hills, OH Cum LaudeMoser, Alison LynnColumbia Station, OHMosier, Michelle Renee Toledo, OHMurphy, David Robert North Olmsted, OHMusitano, Anne Christine Fairlawn, OH Cum LaudeNakhla, Michael Ezzat EL Minya, EgyptNarsinghani, Michele Prem Columbus, INNelson, Erica E Chicago, IL Magna Cum Laude Facts & Comparisons Awardof Excellence in ClinicalCommunication7

Undergraduate Program:Bachelor of Science in the Pharmaceutical Sciences:The undergraduate program in pharmaceutical sciences introducesstudents to the exciting areas of drug discovery, drug delivery, drug action,drug distribution and pharmacoeconomics. The 4-year program builds astrong science foundation, develops essential laboratory skills, and providesthe experience and training necessary for graduate education, graduateprofessional education, or a health-related career. Our BSPS graduates willfill positions as skilled researchers and professionals in marketing,economics, regulations, and clinical affairs.Our recruitment efforts are producing outstanding classes with GPAs atthe end of first quarter averaging 3.01 (28.2% with GPA >3.5) and aretention rate of 87.5%. At the end of Spring Quarter ’08, our BSPSprogram could be summed up with these impressive descriptors: 66%GPA > 3.0; mean cumulative grade-point average of 3.17; 33% hadUniversity Honors status upon entry into the College; Female/male ratio(55/45); 21% from minority-presence groups.BSPS students are excited about research, as evidenced by theirparticipation in undergraduate research projects (18 students), competitions(6 students in the Denman Undergraduate Research Competition) andposter presentations (6 students posters in our 2nd Annual CollegeResearch Day). Since the start of the BSPS Program, of the 1198 studentswho enrolled, 435 graduated with BSPS degrees, 85 transferred intoPharmD program (57 Early Admissions Pathway matriculators), 472 arestill enrolled in the BSPS program, and 149 left the program.We graduated 80 students in the BSPS program and 25 in the EAPprogram in 2007. Of this group, 47 students graduated with honors and/ordistinction.Linda Tran, BSPS Student –Linda is a unique young lady inmany ways. Her enthusiasm forlife, eagerness for learning andlove of OSU are abundantlyapparent when you meet her. Ata young age, Linda learned thathard work and perseverancewere going to be the keys tosuccess and that she wanted tocontribute to society in ameaningful way.Growing up in Cleveland, Lindaknew she wanted to go tocollege. While visiting her cousin,Nancy, at Ohio State, she wasintroduced to the profession ofpharmacy. Linda recognized thiswas the career that matched hergoals in life.If Nancy was a familyinfluence, Dr. Jim Dalton (formerChair of Pharmaceutics) was aprofessional influence. Workingin his lab (studying flavopiridol,an anti-cancer drug) gave Lindavaluable research experienceand she credits Dr. Dalton withgiving her the opportunity to besuccessful inside and outside ofdidactic work. Her selfdetermination allowed her tograduate with a BS degree inPharmaceutical Sciences, summacum laude with distinction andhonors, and receive the FacultyAward in 2008.Cory Vela, BSPS Student –Cory knew he wanted to studypharmacy while still in high schoolin Chicago. His decision to cometo OSU was influenced by thereputation of the BSPS Program,which will be his path to thePharmD. He has spent most of histime at OSU working in the lab ofDr. A. Douglas Kinghorn, studyingnew natural productantileishmanial agents found intropical plants. One day, thesenovel agents may prove to beuseful drugs for the treatment orprevention of this tropical disease.The only undergraduate studentpresently in the lab, Cory worksalongside graduate students andother researchers. His interactionswith them, and with Dr. Kinghorn,will serve him well in his futureprofessional life.In this academic environmentCory has discovered theemerging discipline,translational science (translatingresearch from the laboratorybench to the patient and backagain to the lab). It is Cory’s hopeto earn his PharmD/PhD and finda rewarding position in this field,helping to bridge the gapbetween the patient and theirhealth and the scienceoccurring in the laboratory.9

Bachelor of Science in Pharmaceutical Sciences Graduates (2007-2008)Name Hometown HonorsAbdi, Dahir AbdillahiMogadishu, SomaliaAlbright, Joseph Andrew Powell,OHAllen, Samuel RobertZanesville, OHAlwattar, Raghad Dublin, OH Magna Cum LaudeAmendolara, Mallory Ann Canfield, OH Cum LaudeAmornyard, Melinda Newark, OH Summa Cum Laude withDistinction & HonorsBackie, Katrice MCanton, OHBarnela, Vishal SatishChapel Hill, NCBauer, Julie Erin Wilmington, OH Cum LaudeBeaucage, Catlin Elizabeth Woodville,OHBentley, Taylor EliseGrove City, OHBexfield, Cory E Mt. Sterling, OH Cum LaudeBierbaum, Chad Michael Cincinnati, OH Magma Cum LaudeBok, JoshuaDover, OHBonfiglio, Molly SNorth Olmsted, OHBonsell, Renee Catherine Mount Vernon, OH Magna Cum LaudeBoyko, Alena VGalloway,OHBray, Whitney Michelle Plano, TXBrew, EmmaColumbus, OHBui, Annah MPickerington, OHCline, Jessica Ren'ee Westerville, OH Magna Cum LaudeClose, Joshua ThomasNorth Canton, OHCondra, Benjamin T Bellbrook, OH Magna Cum LaudeCook, Catherine EWarren, OHDalton, Dwan AllenWashington, D.C.Darling, Jerome Alexander Lyndhurst, OHDeJovine, Thomas Joseph Aurora, OH Magna Cum LaudeD'Epiro, Giselle Dublin, OH Cum LaudeDovyak, Sara Catherine Gallipolis, OHDrabick, Zachary Ross McClure East Sparta, OHFarrell, Mathew DavidRavenna, OHFilicky, Kristin NicoleCanton, OHFitz, Katherine RNorthville, MIFlinn, Nicole Elizabeth Kenton, OH Magna Cum LaudeFrangopoulos, Christoforos M Youngstown, OH Cum LaudeGalica, Ryan Joseph Canal Fulton, OH Magna Cum LaudeGallow, Brian BurdfieldWest Chester, OHGarrison, Kimberly AnnDublin, OHGatton, Andrew Douglas Nashport, OH Cum LaudeGonzalez, Allison Marie Mentor, OHGordon, Amanda MWeirton, WVGraff, Heather LNashport, OHHackett, Ryan PatrickYoungstown,OHHan, Helen LSandusky, OHHayes, Christopher Dale Delaware, OHHeglas, Kimberly Diane Strongsville, OH Magna Cum LaudeHeine, Alexander Robert Berea, OH Cum LaudeHill, Chennel ShawnteToledo,OHHipsher, Amanda Nichole Fostoria, OH Cum LaudeHobson, Benjamin TJeromesville, OHHoffman, Rachel Marie Aurora, OH Cum LaudeHoffmann, Ashley Susanne Logan, OHHughes, Rachel M Grafton, OH Cum Laude with DistinctionHunt, Julie AinneNorth Branch, MIJayadeva, Taniya Jeewani Kandy, Sri Lanka With DistinctionJohnson, Christina NCanton, OHJones, Callie Ann Kirtland, OH Cum LaudeJoy, Maria Dublin, OH Cum Laude10

Name Hometown Honors AwardsKemp, Ryan CharlesSt.Clairsville, OHKim, Miha ChristinaSeoul, South KoreaKrebs, Scott MichaelSagamore Hills, OHLao, Louis Gahanna,OH Cum LaudeLapp, Aaron B Beaver, OH Cum LaudeLim, TaeheeSeoul, South KoreaLin, Daniel Beavercreek, OH Cum LaudeLiu, DanielColumbus, OHMa, Zhixian Jinhua, Zhejiang, Magna Cum LaudeP.R. ChinaMalloy, JeffreyBroadview Heights, OHManley, Joshua Clark Galloway, OH Magna Cum Laudewith DistinctionMarshall, Heidi LynnUniontown, OHMaschke, AndrewMt. Gilead, OHMason Jr., Keith JColumbus, OHMatsko, Jessica E Chesterland, OH Cum LaudeMcAlexander, Jonathon Joseph Columbus, OHMcFadden, Linsey Sue Springboro, OH Magna Cum Laudewith DistinctionMcNaughton, Maren Elizabeth Columbus, OHMehta, Neeraj Centerville, OH Magna Cum LaudeMunch, Kyle AGeneva, ILMurrell, Rashida KGahanna, OHMuteithia, Ivy N Nairobi, Kenya With DistinctionNguyen, Ann Anh DaoWest Chester, OHNguyen, NancyNewark, OHNguyen, Trang Thixuan Columbus, OH Cum LaudeNwaneri, Stanley Okechukwu New Carrollton, MDNzongi, Caroline Mutheu Nairobi, KenyaOsborne, Azzie ColeWaverly, OHPanning, David Michael Akron, OHPark, Hae NaSeoul, South KoreaPatankar, Chetana St. Mary's, PA With Distinctionand HonorsPatel, Niti Columbus, OH Magna Cum LaudePatel, Prachi Shirish Vadodara, Gujarat/India Cum Laudewith DistinctionPeprah, Akwasi BAccra, GhanaPham, Marie ThiBrunswick, OHPierpont, Jennifer Elizabeth Xenia, OHPopelka, Thomas C Dublin, OH Cum LaudeRichmond, Jessica Jaye Loveland, OHRussell, Heather MMedina, OHSalvaggio, SamanthaBrecksville, OHSandin, Jessica Lynne Brunswick, OH Magna Cum LaudeSchaad, Angela FayMansfield, OHSchaeff, Alyssa MCenterville, OHSchenck, JessicaKettering, OHSchmidt, Brittany Marie West Chester, OH Magna Cum Laude AIHP AwardSens, Anthony Michael Lewis Center, OHSevern, Vincent A Lyndhurst, OH Magna Cum LaudeShin, Tiffany R Cincinnati, OH Summa Cun LaudeSkomrock, Lindsay K Painesville, OH With Distinction &HonorsSmith, Robert Vincent Greenfield, OH Magna Cum LaudeStanford, Dion DAkron, OHSteichen, Lindsey Avon, IN Cum Laude11

Name Hometown Honors AwardsSuntay, Mark ACincinnati, OHTraeger, Jessica Sharon Beachwood, OH Magna Cumn LaudeTran, Linda Cleveland, OH Summa Cum Laude Faculty Awardwith Distinction &HonorsValentine, Michelle Nicole Temperance, MIVanderman, Adam J Cincinnatti, OH Magna Cum LaudeVang, Jonathan Tuan Columbus, OH Cum LaudeVelt, Doreen MarieHilliard, OHVishnepolsky, DanaSylvania,OHVon Schwarz, Amy Lynn Austintown, OHWall, Kati L Dublin, OH Cum LaudeWalters, Janet North Royalton, OH Cum LaudeWang, Mary MengqiuGrove City, OHWhitacre, Leslie MBethel, OHWhitlock, Ambrea PBowling Green, OHWilkerson, Kelsi Leanna Granville, OHYoung, Mallory ErinUpper Arlington, OHZemanek, Melissa Marie Highlands Hts, OHSummary of Student Enrollment and GraduatesCurrent Enrollments (Autumn 2007) :Residential PharmD program 467Non-Traditional PharmD (NTPD) 61Graduate Programs 98BS Pharmaceutical Sciences 489TOTAL 1,115Student Enrollment TrendsGraduates (includes Autumn ’07 – Summer ’08 ) :Residential PharmD program 112Non-Traditional PharmD (NTPD) 24Graduate Programs 30BS Pharmaceutical Sciences 127TOTAL 29312

Graduate Programs in Pharmacy:The Graduate School devoted considerable effort in evaluation of thecollege’s Ph.D. program during autumn quarter. This evaluation wasrequested by the Graduate School as part of its university-wide assessment ofdoctoral programs at The Ohio State University. Data related to the size andquality of the program for the 2002–2007 period were evaluated by a 13-member committee appointed by the Graduate School.The Graduate School judged the doctoral program in Pharmacy to be“High Quality”, the highest rating possible on a six-item rating scale. Only12 of the University’s 90 doctoral programs received the highest rating.The main findings of the Graduate School response to the College ofPharmacy’s Doctoral Program Assessment and Plan were:❖ All measures of student and faculty quality provide evidence of ahigh quality doctoral program in the College of Pharmacy.❖ The Graduate School believes that the college’s efforts to increasethe diversity of its student body are a model for other units toemulate.❖ Plans for a new Translational Science track in the College ofPharmacy’s doctoral program address emerging opportunities inpharmacy and tie in nicely with the university’s Clinical andTranslational Science Award Program efforts.William HaytonAssociate DeanProductivity metrics includedpublications, degrees awarded, andsponsored research funding. Pharmaceuticsand medicinal chemistry/pharmacognosy,showed the highest activity in publicationsby faculty and Ph.D. graduates, degreesawarded, Ph.D. enrollment and sponsoredresearch funding.We are very proud of this distinction andcredit our exceptional faculty, our qualitystudents and our diligent staff for all theircontributions to our graduate program.Jia (Jackie) Ji, PhD Student, ishard at work now in Bejing,China, working on completingthe NIH/Fogarty InternationalClinical Research ScholarsFellowship, a one-year clinicalresearch training experiencefor graduate-level U.S. studentsin the health professions. Thisis an opportunity for highlymotivated individuals toexperience mentored researchtraining at top-ranked NIHfundedresearch centers inChina.Jia’s strong interest inbiopharmaceutics andpharmacokinetics led her toOSU and her skills andacademic strength in this fieldmade her competitive for thisprestigious award.Trained in Pharmacy inBejing, Jia has alreadyauthored six research papers inrefereed journals, quite anaccomplishment for a graduatestudent. In addition Jiareceived numerous academichonors and awards during herPharmacy degree program atBejing Medical University.13

MS and PhD Graduates (2007-2008)Master of Science (MS)Name Specialization AdvisorAhn, Sunjoo Pharmaceutics James T. DaltonBeyer, Andrew Paul Pharmaceutical Administration Sheryl L. SzeinbachChang, Elizabeth H Pharmaceutical Administration Craig A. PedersenDeMarco, Leigh Brooke Health-System Pharmacy Administration Craig A. PedersenEl-Hajj, Raed Pharmacology Dennis B. McKayGarg, Vivek Pharmacology Keli HuHolley, Michelle Health-System Pharmacy Administration Craig A. PedersenKawchak, Brook Smith Health-System Pharmacy Administration Craig A. PedersenLi, Chien-Ming Pharmaceutics James T. DaltonMukherjee, Mitali Smarajit Medicinal Chemistry and Pharmacognosy Karl A. WerbovetzNorman, Christy M Health-System Pharmacy Administration Craig A. PedersenPatel, Binita Health-System Pharmacy Administration Sheryl L. SzeinbachPorteus, Michael D Pharmaceutical Administration Craig A. PedersenSchaefer, Kevin Frederick Medicinal Chemistry and Pharmacognosy Pui-Kai (Tom) LiTiwari, Ruchi Health-System Pharmacy Administration Craig A. PedersenWang, Yu-Chieh (Jack) Medicinal Chemistry and Pharmacognosy Ching-Shih ChenWilliams, Jonathan Paul Health-System Pharmacy Administration Craig A. PedersenXiong, Lianjie Pharmaceutics Sylvan G. FrankYang, Liuqing Pharmaceutics Tom D. SchmittgenPh.D.Name Specialization AdvisorBhosle, Monali Pharmaceutical Administration Rajesh BalkrishnanGibbs, Seth Thomas Pharmaceutics Duxin SunHan, Bing Pharmacology John A. BauerHuang, Yongcheng Pharmacology Lakhu M. KeshvaraJayawant, Sujata Satish Pharmaceutical Administration Rajesh BalkrishnanLai, Ju-Ping Pharmaceutics James T. Dalton/Daren L. KnoellMa, Thong Pharmacology Kari HoytPandit, Bulbul Medicinal Chemistry and Pharmacognosy Pui-Kai (Tom) LiPawaskar, Manjiri Pharmaceutical Administration Rajesh BalkrishnanYakovich, Adam J Medicinal Chemistry and Pharmacognosy Karl A. WerbovetzZhao, Zhuojun Pharmaceutics Mamuka KvaratskheliaFellowships and Scholarly Awards14StudentGibbs, SethMao, YichengRegan, Nicholas/Richard, JulianRich, Wendy,/Schneider, RyanRozewski, DarleneSchneider, RyanVisaria, JayWeng, Shu-Chuan (Nicole)Xiong, LianjieYang, XiaojuanYe, DengStudentBellebaum, KatherineCarrier, RaeannJi, Jia (Jackie)Stoudmire, JaketaTiwari, RohitWang, Yu-Chieh (Jack)Weng, Shu-Chuan (Nicole)FellowshipCancer Drug Discovery & Development FellowshipNanoscale Sci & Engineering (NSEC)CBI FellowshipAFPE FellowshipsNanoscale Sci & Engineering (NSEC)Popat Patil Fellowship for Graduate Research in PharmacologyDev Pathak Drug Distribution & Public Policy FundChih-Ming & Jane Chen FellowshipSylvan G. Frank FellowshipNanoscale Sci & Engineering (NSEC)Novartis FellowshipRaymond Doskotch Graduate Student FellowshipAwardAgency for Healthcare Research and Quality (DHHS)Popat Patil Fellowship for Graduate Research in PharmacologyFogarty International Clinical Research ScholarNIH/NIAID FellowshipMAGSS 2007 “Best Poster Presentation Award”NIH National Graduate Student Research FestivalAAPS Graduate Student Symposium Drug Design and Discovery

FacultyThe College of Pharmacy faculty are truly outstanding, providing excellent teaching and learningopportunities to students in both large lectures and small group settings. They are engaged in excitingscholarship and state-of-the-art research in pharmacy and the pharmaceutical sciences. Our faculty andstaff serve the University and profession at regional and national levels and are involved in stimulatingoutreach and engagement activities. The high quality of our faculty is reflected in this impressivestatistic: two-thirds of our Pharmacy senior faculty have been honored by their peers and elected asFellows of scientific organizations or professional pharmacy organizations.The number of tenure-track faculty, regular clinical faculty, and instructional staff in Autumn 2007totaled 60.James R. Fuchs joined our College (Division of Medicinal Chemistry andPharmacognosy) this past year looking for a collaborative work environment.He believes he has found just that at Ohio State. He finds the expertise here inthe College and the Medical Center complements his work. You need them andthey need you, says Jim of the colleagues he has found at OSU.BS in Chemistry (University of Toledo) and PhD in Chemistry (Penn State)prepared Jim for a two-year stint as a Research Associate in SyntheticOrganic/Medicinal Chemistry at The Scripps Research Institute, La Jolla, CA.Jim’s research focuses on drug design and synthesis. He often finds inspirationfor his projects in the form of natural products, potentially useful compoundsisolated from natural sources that have already shown interesting anti-cancer or antibiotic activity. For hisresearch group of five (2 undergraduates, 2 graduate students and a post-doc) the ultimate goal is not simplyto prepare these natural products, but to prepare new synthetic drugs with improved biological activity andpharmacological profiles through changes in their structures.Jim, his wife, Andrea, and 1 year-old Sophie are happy to be back home in Ohio and are settling in totheir new home in Columbus.We said good-bye this summer to Philip J. Schneider whosedistinguished history with our College spans 33 years of exceptional service.Director of the Latiolais Leadership Program and clinical professor at The OhioState University College of Pharmacy, Phil’s teaching and research focused onimproving the medication use process and medication-use safety. He developed anationally recognized program for the reporting and analysis of adverse drugevents that led to improvements in the medication use process at the Ohio StateUniversity Medical Center.Phil is a past president of the American Society of Health-System Pharmacists(AHSP) and the American Society for Parenteral and Enteral Nutrition, a widelypublished author and sought-after speaker. Phil was the 2008 recipient of the ASHP Harvey WhitneyAward, the highest award in health-system pharmacy. He received the 2006 ASHP Donald E. FranckeMedal for significant contributions to international pharmacy practice and is active in leadership roles inthe International Pharmaceutical Federation (FIP).In his new position at the University of Arizona Phil is responsible for implementing new academicprograms at the college’s Biomedical Campus in Phoenix, including a PharmD program, innovativehealthcare delivery services that include pharmacists, and translation of research discoveries into practice.15

Faculty Awards and RecognitionsNational RecognitionsRobert A. BrueggemeierAPhA Tyler Prize for Stimulation of Research in the Pharmaceutical Sciences,March 2008Gerald L. Cable AACP Crystal APPLE Award, July 2007Cynthia A. Carnes Fellow, Heart Rhythm Society, May 2008Kristen A. Casper AACP Crystal APPLE Award, July 2007Kenneth K. ChanFellow, American Association for Advancement of Science.George H. Hinkle, Jr APhA Daniel B. Smith Practice Excellence Award, March 2008A. Douglas Kinghorn Fellow, American Society of Pharmacognosy (ASP), in recognition of “continuing highlevel contributions in the field of natural products and a record of sustainedachievement”, July, 2007.A. Douglas Kinghorn Ole Grisvold Award, Department of Medicinal Chemistry, College of Pharmacy, Universityof Minnesota, “in recognition of outstanding contributions in the field of natural productschemistry”, November, 2007Mamuka KvaratskheliaDennis B. McKayNIH Career Development AwardFellow, American Association for the Advancement of ScienceMilap C. Nahata ACCP Model Practice in Clinical Pharmacy Education, April 2008Maria C. Pruchnicki ACCP New Educator Award, April 2008Jennifer L. Rodis APhA Merit Award, March 2008Philip J. Schneider ASHP Harvey Whitney Lecture Award, June 2008College/State AwardsRajesh BalkrishnanBest Research Paper Award (Student Poster Presentation Ala Iaconi). InternationalSociety of Pharmacoeconomics and Outcomes Research Annual Meeting, May 2008Kristen A. Casper Merit Award for poster presentation, APhA, March 2008James A. Coyle Distinguished Paper Presentation, Society of Teachers of Family Medicine, May 2008Louis W. Marcy Distinguished Alumnus Award, OSU College of Pharmacy, May 2008James W. McAuley Preceptor of the Year Award, OSU College of Pharmacy, June 2008Milap C. Nahata Miriam V. Balshone Award for Distinguished Teaching, June 2008Vinita B. PaiBest Original Paper, Pediatric Pharmacy Advocacy Group (PPAG) Annual Meeting,September 2007Craig A. Pedersen Ralph V. Foster Friend of APhA-ASP Award, OSU College of Pharmacy, May 2008Jennifer L. Rodis Preceptor of the Year Award, OSU College of Pharmacy, June 200816

Faculty, National Honors11 faculty Fellows, American Association for the Advancement of Science (AAAS)Jessie L.-S. AuRobert W. BrueggemeierKenneth K. ChanChing-Shih ChenA. Douglas KinghornDennis B. McKayMilap C. NahataM. Guillaume WientjesJohn M. Cassady (emeritus)Popat N. Patil (emeritus)Albert H. Soloway (emeritus)15 faculty Fellows, American Association of Pharmaceutical Scientists (AAPS)Jessie L.-S. AuRobert W. BrueggemeierKenneth K.-H. ChanJames T. DaltonSylvan G. FrankWilliam L. HaytonA. Douglas KinghornM. Guillaume WientjesJohn M. Cassady (emeritus)Louis Malspeis (emeritus)Robert E. Notari (emeritus)Dev S. Pathak (emeritus)Richard H. Reuning (emeritus)Theodore D. Sokoloski (emeritus)Albert H. Soloway (emeritus)3 faculty Fellows, American College of Clinical Pharmacy (ACCP)Joseph F. DastaDaren L. KnoellMilap C. Nahata1 faculty Fellow, American College of Clinical Pharmacology (ACCP)Milap C. Nahata5 faculty Fellows, American Pharmacists Association (APhA)Marialice S. BennettGerald L. CableGeorge H. HinkleMilap C. NahataCraig A. Pedersen4 faculty Fellows, American Society of Health-System Pharmacists (ASHP)George H. HinkleMilap C. NahataPhilip J. SchneiderJerry Siegel1 faculty Member, Académie Internationale d’Histoire de la Pharmacy (AIHP)Robert A. Buerki17

Academic DivisionsA. Douglas Kinghorn arrivedat OSU in 2004 as the inauguralJack L. Beal Professor andChair in Natural ProductsChemistry and Pharmacognosy.Previously, he served on thefaculty of the College ofPharmacy, University of Illinoisat Chicago for over 27 years. Hetrained originally in the UnitedKingdom and obtained a Ph.D.in Pharmacognosy and a D.Sc.in Pharmacy in 1975 and 1990,respectively, both from theSchool of Pharmacy, Universityof London.In addition to his researchand teaching, Doug keeps verybusy as the Editor of theJournal of Natural Productsand as Series Editor in Chief ofthe long-established bookseries, Progress in theChemistry of Organic NaturalProducts. Next June, he will beinducted as an HonoraryMember of the AmericanSociety of Pharmacognosy atits 50th annual meeting inHawaii.Doug lives in the Miranovacondominium in downtownColumbus with his wife, Helen,a graduate in pharmacy fromSt. John’s University. Helen alsoworked for many years inseveral Chicago law firmsbefore retiring.Division of Medicinal Chemistry and PharmacognosyLi, Pui-KaiBrueggemeier, Robert W.Carcache de-Blanco, EsperanzaChen, Ching-ShihCurley, Robert W.Kinghorn, A DouglasLi, ChenglongTjarks, WernerWerbovetz, Karl A.Fuchs, James R.Cassady, John M.Doskotch, RaymondJagadeesh, JogikalOlson, CarterRobertson, LarrySoloway, AlbertAssociate Professor and Interim ChairProfessor and DeanAssistant Professor(joint, Pharmacy Practice and Administration)ProfessorProfessorProfessor and Jack L. Beal ChairAssistant ProfessorAssociate ProfessorAssociate ProfessorAssistant ProfessorEmeritus Professor and DeanProfessor EmeritusProfessor EmeritusProfessor EmeritusProfessor EmeritusEmeritus Professor and DeanWe take for granted our cold and flu medicines, our headachetablets and our antibiotics. But safe and effective medications don’tgrow on trees—or do they? Scientists are returning to nature as theinspiration for new drugs. For thousands of years, natural productshave played an important role in developing safe effectivemedications to treat and prevent human diseases. Scientists havefound that organic compounds from natural materials includingterrestrial plants, microorganisms, marine and terrestrial organismsare of interest both in their natural form and as templates forsynthetic modification. These approved substances, representativeof very wide chemical diversity, together with several other naturalproducts or their analogsundergoing clinical trials,continue to demonstratethe importance ofPui-Kai (Tom) LiChaircompounds from natural sources in modern drugdiscovery efforts.Virtually every pharmacological class of drugsincludes a natural product prototype. The future ofhigher plants as sources of medicinal agents for use ininvestigation, prevention, and treatment of diseases isvery promising. Over 20 new drugs from naturalproducts have been launched on the market in westerncountries since 2000 .18

Division of PharmaceuticsHayton, William L.Au, Jessie L.-S.Chan, Kenneth K.-H.Dalton, James T.Frank, Sylvan G.Johnston, Jeffrey S.Kvaratskhelia, MamukaLee, Robert J.Schmittgen, Thomas D.Sun, DuxinWientjes, M. GuillaumeMalspeis, LouisNotari, Robert E.Sokoloski, Theodore D.Staubus, AlfredProfessor, Associate Dean andInterim ChairDistinguished University ProfessorProfessorProfessorProfessor and Associate DeanSenior LecturerAssociate ProfessorAssociate ProfessorAssociate ProfessorAssistant ProfessorProfessorProfessor EmeritusProfessor EmeritusProfessor EmeritusAssociate Professor EmeritusOne feature that distinguishes ourprogram from most national programs is ourbalanced involvement in both major areas ofpharmaceutics: pharmacokineticspharmacodynamicsand drug delivery. Ourfaculty is internationally known for cancer drugpharmacokinetics-pharmacodynamics and iscritical to the cancer program on campus.Expertise in drug discovery and development,mass spectrometry, and proteomics within thedivision are other areas of strength that serve asadditional conduits for research collaborationand recognition with campus and nationalpeers.William HaytonInterim ChairEmployment prospects for graduatinggraduate students remain outstanding, withrecent graduates accepting positions in major pharmaceutical companiesimmediately after graduation.Thomas Schmittgen, AssociateProfessor – After earning hisPhD in Pharmaceutics here atOSU, Tom headed off to Californiafor a post-doctoral position at theUniversity of Southern California.After ten years on the west coast,Tom decided he wanted to becloser to a comprehensivemedical center where he wouldfind more resources andexpertise to continue hisresearch interests.He found what he was lookingfor at OSU. The Ohio StateUniversity Medical Center is oneof the largest and most diverseacademic medical centers in thecountry and one of the nation’spreeminent biomedical researchcenters. Here Tom found acollegial research environment,easy access to patients in aclinical setting and top-notchscientists as colleagues.Tom’s research focus is on therole of microRNA in cancer. Incollaboration with surgeons atMemorial Sloan Kettering CancerCenter (NYC), Tom is working todevelop new diagnostics forpancreatic cancer.Tom’s family includes wife,Janet, a Walgreens pharmacistand OSU alum, and two sons, Erik(University of Cincinnati) andEvan (Granville High School).19

Division of PharmacologyWallace, Lane J.Elton, Terry S.Hoyt, Dale G.Hoyt, Kari R.Hu, KeliKeshvara, Lakhu M.Kwiek, NicoleMcKay, Dennis B.Young, Anthony P.Professor and ChairProfessorAssociate ProfessorAssociate ProfessorAssistant ProfessorAssistant ProfessorClinical Assistant Professor/Assistant Director for EducationalOutreachProfessorProfessorDennis McKay, Professor.Honored in 2007 as a AAASfellow, Dr. Dennis McKay holdsthe distinction of beingrecognized by AAAS for bothresearch and teaching. Hisstudents will tell you that histeaching style brings science tolife for them.After 25 years at OSU, Dennis’enthusiasm for his research hasnot waned. He is currentlystudying a novel class of drugsthat target nicotine receptorsused in smoking cessation.These receptors have beenassociated with a variety ofdisease states includingAlzheimer’s Disease, Parkinson’sDisease, schizophrenia, anxietyand depression. Dennis’ group isstudying drug discovery, whichcoupled with pharmacologicalapproaches, they hope willproduce new treatmentstrategies for nicotine-relateddiseases.Every morning Dennis and hiswife, Susan, arrive on campustogether (Susan is a ResearchAssociate at the OSU MedicalCenter). A daughter in LawSchool at OSU, one son anengineer at GE and another ajunior at Arlington High School,complete the McKay family.Burkman, AllanFeller, DennisGerald, MichaelPatil, Popat N.Uretsky, Norman J.Professor EmeritusProfessor EmeritusProfessor EmeritusProfessor EmeritusProfessor EmeritusAmong the discoveries made by our pharmacology faculty this year was a veryinteresting research finding by Terry Elton that suggests a potential cause for somekinds of mental retardation. As often happens in research, this work evolved from adifferent project when Terry began looking at whether findings from hiscardiovascular studies had a correlation in other organ systems. This led Terry toexplore a possible relationship between Down syndrome and miRNAs.Bioinformatics analyses showed that the human chromosome causing Downsyndrome harbors five miRNA genes. Studies ofbrain tissue demonstrated that all of these miRNAsare over-expressed in human fetal Down syndromebrain samples. Furthermore, methyl CpG bindingprotein (MeCP2), a protein linked to a spectrum ofneurocognitive diseases, is under-expressed inhuman fetal Down syndrome brain samples. Thegroup found that miR-155 inhibits expression ofMeCP2, resulting in cognitive deficiencies.Thus, the extragenes for miR-155in Down syndromemay produce extraLance WallaceChairmiR-155 which inturn decreasesMeCP2 to levelsbelow thosenecessary for normalcognitive function.Professor Terry Elton20

Division of Pharmacy Practice and AdministrationNahata, Milap C.Balkrishnan, RajeshBeatty, StuartBennett, Marialice S.Brackett, Carolyn C.Buerki, Robert A.Cable, Gerald L.Carnes, Cynthia A.Casper, Kristin A.Clark, ColleenCoyle, James D.Emptage, Ruth E.Hale, Kenneth M.Hall, Laura E.Hinkle, Jr., George H.Huston, Jeffery L.Lacombe, VeroniqueProfessorKelley, Katherine A.Knoell, Daren L.Legg, Julie E.Mehta, Bella H.McAuley, James W.Murphy, Christine C.Pai, Vinita B.Pedersen, Craig A.Pruchnicki, Maria C.Rodis, Jennifer L.Schneider, Philip J.Seoane-Vazquez, Enrique C.Siegel, JerrySzeinbach, Sheryl L.Dasta, Joseph F.Pathak, Dev S.Reuning, Richard H.Visconti, James A.Professor and ChairAssociate Professor and Merrell Dow ProfessorAssistant Professor of Clinical PharmacyProfessor of Clinical PharmacyAssociate Professor of Clinical PharmacyProfessorClinical Assistant Professor and Director, Experientialand Outreach ProgramsAssociate ProfessorAssociate Professor of Clinical PharmacyClinical AssistantProfessorAssociate Professor ofClinical PharmacyClinical AssistantProfessorClinical AssociateProfessor and AssistantDeanClinical AssistantProfessorAssociate ProfessorClinical AssistantProfessorMilap C. NahataResearch AssistantChairClinical AssistantProfessor and Assistant Dean for AccreditationAssociate ProfessorClinical Assistant ProfessorAssistant Professor of Clinical PharmacyAssociate ProfessorClinical Assistant ProfessorAssistant Professor of Clinical PharmacyAssociate ProfessorAssistant Professor of Clinical PharmacyAssistant Professor of Clinical PharmacyClinical Professor and Director, Latiolais LeadershipProgramAssistant ProfessorClinical Professor and Assistant Dean,Medical Center AffairsProfessorEmeritus ProfessorEmeritus ProfessorEmeritus ProfessorEmeritus ProfessorJames Coyle, AssociateProfessor, can reallycall OSU his home. After earningBS and PharmD degrees andcompleting a post-doctoralfellowship in clinicalpharmacokinetics at OSU, Jimjoined the faculty at theUniversity of Iowa. Returning toOSU in 1986, Jim joined theDivision of Pharmacy Practiceand Administration and iscurrently an Associate Professorof Clinical Pharmacy.Jim's expertise in the areasof clinical pharmacokinetics andcardiovascular disease and itsrisk factors are put to good usein his practice setting, RardinFamily Practice Center, thelargest of the OSU Department ofFamily Medicine's primary carecenters. He currently serves asDirector of the CollaborativeAntithrombotic ManagementProgram and runs the CAMPAnticoagulation Clinic at Rardin.Jim teaches a variety of topicsin the OSU Pharm.D. program,including physical assessment,principles of pharmacotherapy,valvular heart disease and itstreatment, stroke and itstreatment, and P4 experientialrotations at his practice site.Jim, his wife (Cynthia Carnes,also a pharmacy professor atOSU), and their son, Michael,live in Upper Arlington. Jim'sdaughter, Christen, son-in-law,Jason, and granddaughter,Audrey, live in Worthington.21

Vision and Strategy GroupTwenty-nine faculty in three academic tracks (tenure track, with primaryfocus on teaching and research; regular clinical track, with primary focus onteaching and practice; and auxiliary track, with primary focus in any areae.g., teaching, practice or administrative work) comprise our division.In 2007, in response to recommendations from a division-wideassessment, our division engaged in a process of revising and renewing itsvision and strategic plan. In order to achieve this task, the division formed aVision and Strategy Group (VSG) that would help to vividlyarticulate the direction of the Division and guide theallocation of energy and resources. Nine juniorand senior faculty and the Division Chair led this effort withthe help of a University human resources consultant.The newly created vision will be used to enhancestrategic faculty hiring,improve facultyretention andencourage acollaborativeenvironment.This vision aligns thework of the Division withOSU Medical Center’s clinicaland translation science award fromNIH and will be used as thefoundation to create anoptimal administrativestructure.New Vision and Strategic Priorities22

Department of Pharmacy, OSU Medical Center RosterThe College of Pharmacy and OSU Medical Center, Department of Pharmacy, work closely to achieve our mission andgoals related to PharmD and Graduate Programs. We collaborate in teaching, research, practice and outreach activities.The OSU Medical Center is the primary site for the advanced pharmacy practice experiences in the PharmD Program.Many pharmacy residents from the medical center complete a teaching certificate at the College. The collaboration isfacilitated by Jerry Siegel, Senior Director of the Department of Pharmacy (and Assistant Dean at the College ofPharmacy) and Milap Nahata, Chair of the Pharmacy Practice and Adminstration Division (and Associate Director,OSU Medical Center, Department of Pharmacy).Siegel, JerryGriffith, NieshaSmeenk, DavidHaas, DanJordan, TrishaTubbs, CrystalHafford, AmandaEskander, NatoshaForrey, RyanPrier, BethKeating, EllenSeth, Shiv K.Winters, HolliGerlach, AnthonyMurphy, ClaireTschampel, Marva M.Parbhoo, RupalMirtallo, Jay M.Shirk, Mary BethPickworth, Kerry K.Blais, DanielleAbel, ErikBoyd, MikeHevezi, MargieSnider, MelissaVotolato, NicholasPell, Lindsay J.Doepker, BruceSenior Director, PharmaceuticalServices, Clinical AssociateProfessor, Assistant Dean Collegeof PharmacyAssociate Director, ResidencyProgram CoordinatorAssociate Director of PharmacyAssociate Director of PharmacyAssociate Director, ResidencyCoordinatorAssistant Director, ResidencyCoordinatorAssistant DirectorAssistant DirectorAssistant DirectorAssistant DirectorSpecialty Practice Pharmacist,Medication Utilization EvaluationSpecialty Practice Pharmacist,Internal Medicine/NephrologySpecialty Practice Pharmacist,Solid Organ TransplantSpecialty Practice Pharmacist,Critical CareSpecialty Practice Pharmacist,Critical CareSpecialty Practice Pharmacist,Drug InformationSpecialty Practice Pharmacist,Drug InformationSpecialty Practice Pharmacist,Nutrition Support/Surgery,Specialty Practice Pharmacist,Emergency MedicineSpecialty Practice Pharmacist,CardiologySpecialty Practice Pharmacist,Cardiothoracic SurgerySpecialty Practice Pharmacist,Cardiothoracic SurgerySpecialty Practice Pharmacist,ElectrophysiologySpecialty Practice Pharmacist,Cardiology (Outpatient)Specialty Practice Pharmacist,Cardiology (Outpatient)Specialty Practice Pharmacist,NeuropsychiatrySpecialty Practice Pharmacist,Critical CareSpecialty Practice Pharmacist,Critical CareVoth, LauraSpecialty Practice Pharmacist,Progressive CareGanio, Michael C. Staff Pharmacist, RehabilitationEdwards, Cowan Specialty Practice Pharmacist,Nuclear PharmacyFudge, Robert Specialty Practice Pharmacist,Investigational DrugsHawksworth, Kim Specialty Practice Pharmacist,Web Manager/DeveloperGardner, Debra K. Specialty Practice Pharmacist,Women and InfantsLehman, Katherine Joy Specialty Practice Pharmacist,Critical CareTurowski, Robert Specialty Practice Pharmacist,Hematology/OncologyGoff, DebraSpecialty Practice Pharmacist,Infectious DiseasesTaylor, Jeremy Specialty Practice Pharmacist,Infectious DiseasesBauer, KarriSpecialty Practice Pharmacist,Infectious DiseasesRoddy, Julianna Specialty Practice Pharmacist,Hematology/OncologyLi, QuanSpecialty Practice Pharmacist,Hematology/OncologyHanje, Jennifer Specialty Practice Pharmacist,Hematology/OncologyHartman, Amber Specialty Practice Pharmacist,Pain/Palliative MedicineBechtel, Thomas Specialty Practice Pharmacist,Hematology/OncologyBerger, Michael Specialty Practice Pharmacist,Hematology/OncologyMcPherson, Elizabeth Clinical Generalist, James CancerHospitalMcNulty, Robert Specialty Practice Pharmacist,Clinical InformativePultz, Jr., Andrew J. Specialty Practice Pharmacist,James Cancer HospitalChalupa, Donald L. Specialty Practice Pharmacist,Investigational DrugsSchieber, Ariane Specialty Practice Pharmacist,Internal MedicineGoodman, Erin Specialty Practice Pharmacist,Critical CareVenn, JeanStaff Pharmacist, UniversityHospitals EastBlazer, Marlo Specialty Practice Pharmacist,Hematology/OncologyPoirier, Jessica Specialty Practice Pharmacist,Hematology/OncologyKemper, Dorothy Office Associate23

Administrative and Professional StaffOffice of the DeanBrueggemeier, Robert W.Eshbaugh, Susan B.Frank, Sylvan G.Hayton, William L.Hale, Kenneth M.Kelley, Katherine A.Siegel, JerryTaylor, RoriProfessor and DeanOffice AssociateAssociate Dean, Professional ProgramsAssociate Dean, Graduate and Research StudiesAssistant Dean, Professional & External AffairsAssistant Dean, Assessment & AccreditationAssistant Dean, Medical Center AffairsAssistant to the DeanBetsy Bulgrin, DivisionCoordinator for Pharmacology,and husband, Dick, live innorthwest Columbus. Betsy hasbeen at OSU for 9 years andreally enjoys working with thefaculty and staff here in theCollege. Apparently, the feelingis mutual, as Betsy received theOutstanding Staff Award in 2008.Said one of her nominees aboutBetsy, “Without Betsy'sefficiency and excellent workethic, the Pharmacology Divisionwould not be nearly asproductive as it is today.” and“Her dependability is a byword inthe department and we can relyon her to finish anything that weask”.The Ohio Stadium is visiblefrom Betsy’s office window andgives her a clear view of the OSUMarching Band at practice.Betsy and Dick enjoy biking theColumbus paths and ‘raised-bed’gardening at their home inWorthington. Their oldestdaughter graduated from OSUwith a BS in Human Ecology/Nutrition in June, 2008 and theiryoungest daughter is at KentState University, majoring infashion.Because of the small size ofour college, Betsy is grateful toget to know the faculty andgraduate students in her divisionand is always sorry to see thestudents leave upon graduation.Office of Professional ProgramsFrank, Sylvan G.Hegler, Barbara A.Office of Professional Experience ProgramsCable, Gerald L.Blight, ThalliaMakarich, JosephMurphy, ChristineOffice of Graduate and Research StudiesHayton, William L.Brooks, Kathleen I.Eshbaugh, Susan B.Wray, Dawn A.Office of Student AffairsDeters, Heather S.Draudt, LaurelEvans, JuneHerbert, NikkiMiller, JulieOrozco, JoeCentral Business OfficeDelffs, ErinBlakemore, BrianEmmenegger, Linda S.Goff, AmandaVornholt, GailAssociate Dean, Professional Programs and InterimDirector, Non-Traditional Doctor of PharmacyProgramProgram Manager, Non-Traditional Doctor ofPharmacy, Continuing EducationDirector, Experiential and Outreach ProgramsProgram CoordinatorCoordinator, Introductory Practice ExperiencesIntermediate Practice ExperiencesAssociate Dean, Graduate and Research StudiesGraduate Program CoordinatorOffice AssociateLaboratory SupervisorDirector of Student ServicesAcademic Counselor and Staff AssistantCollege RegistrarAcademic Counselor and Staff AssistantProgram AssistantAcademic Counselor and Staff AssistantCollege Fiscal/Personnel OfficerBuilding CoordinatorCollege Procurement CoordinatorGrants ManagerHuman Resources Manager24

Development and Alumni AffairsWeiher, ShannonMarcy, Louis W.McDay, Tanya R.Director of Development and External AffairsDirector of Alumni AffairsDevelopment and Alumni Affairs CoordinatorComputers and InstrumentationFowble, John W.Beranek, EdwardGladden, Jonathan E.Hoerig, CaseyKhurma, AnandLogan, JamesPosey, Bruce C.Stansell, BradDirector, Senior Systems ManagerSystems Developer/EngineerSystems Developer/EngineerSystems SpecialistSystems Developer/EngineerSystems Developer/EngineerSystems ManagerSystems SpecialistDivision Coordinators and StaffBulgrin, BetsyCamm, Carol A.Daniels, AliceScott, Joy E.Turner, SaraWarren, JoniDivision of PharmacologyDivision of PharmaceuticsDivision of Medicinal Chemistry andPharmacognosyDivision of PharmaceuticsDivision of Pharmacy Practice and AdministrationDivision of Pharmacy Practice and Administration25

College of PharmacyAdministrative Organization26

Research and ScholarshipThe research program in the College remains robust.Faculty authored or co-authored 240 peer-reviewedjournal articles and book chapters. Research expenditures(7/1/06 – 6/30/07) topped $5.4 M and new awards(7/1/07 – 6/30/08) totaled over $8 M for 54 projects.William HaytonAsociate DeanFigure 4. Distribution of Research Funding by SourceFrom ‘Bench’ to ‘Marketplace’…Did you ever wonder how an ‘idea’ generated in the laboratory makes its way from thatscience bench to your medicine chest as a life-saving, safe, medication? Technology transfer,moving novel ideas and technologies from the laboratory to the marketplace, guaranteesthat Ohio’s citizens not only have access to the latest technology, but also reap theeconomic benefits from the commercialization of new ideas.It happens here all the time. One promising new cancer therapy created in a pharmacylaboratory is now on an accelerated pace toward testing thanks to a new licensingagreement between Ohio State and a New Jersey-based drug development firm, ArnoTherapeutics Inc.The agents are two small molecules that are considered to have powerful cancer-fightingproperties. They were developed by Dr. Ching-Shih Chen, the holder of the Lucius A.Wing Chair of Cancer Research and Therapy in Ohio State’s Comprehensive CancerCenter and professor of pharmacy and internal medicine. The molecules trigger cancer cellsto self-destruct by blocking the transmission of key informationfrom the cell surface into the cell interior. In laboratory studiesthese agents also were shown to interact with existing cancertherapies in promising ways.The College of Pharmacy ranks #2 among all colleges at OSUin dollars generated in licensing fees and royalties for patents.These funds are shared among the Technology Licensing andCommercialization Office, the College of Pharmacy and theinventor. The College channels its portion into researchprograms in the college, supporting researchers and shoring upinfrastructure.Professor Ching-Shih Chen27

College Research Day 2008“Pharmaceutics in the New Millennium: If Only Drugs Could Fly”On May 19, 2008, faculty, staff, students, researchers and colleagues of Dr.Sylvan Frank gathered at the Biomedical Research Tower to honor him andshowcase the research activities of the College. The day-long event included 80poster displays of faculty and student research and a symposium in the area ofpharmaceutics research. This year, the symposium recognized Sylvan Frank,Associate Dean for Professional Programs and Professor of Pharmaceutics.During his distinguished career in pharmaceutics education and research,Dr. Frank advised 32 graduate students and 8 postdoctorals. Many returned onthis day to honor him and speak at the symposium. A reception followed thesymposium allowing for informal interactions among students, researchers,faculty and invited guests.Dean Brueggemeier opened the symposium and introduced Dr. JosephAlutto, Executive Vice-President and Provost of Ohio State University, whose talk “Partnerships in Academiaand Industry” kicked off the event.Other featured speakers:Marialice Bennett, RPh, FAPhA, Professor of Clinical Pharmacy,College of Pharmacy,The Ohio State University“Clinical Issues with Drug Delivery and Patient Adherence”Shirley Ng, PhD, Director, Formulation Development,Johnson & Johnson Consumer Group.“Challenges in Product Development “Jessica Miller, PhD, Senior Scientist, Product Development,AstraZeneca Pharmaceuticals“Opportunities and Challenges in the Pharmaceutical Sciences: An AstraZeneca Perspective”Yong Cui, PhD, Formulation Scientist,Genentech, Inc.“The Role of a Formulator in Drug Discovery/Development and New Trends”James Lee, PhD, Helen C. Kurtz Professor of Chemical and Biomolecular Engineering,The Ohio State University“Engineering Perspectives of Next Generation Drug Delivery and Devices”❖ ❖ ❖ ❖ ❖ ❖ ❖ ❖ ❖Sylvan G. Frank, PhD,Associate Dean for Professional Programs and Professor of Pharmaceutics,The Ohio State University“Pharmaceutics: A Personal Journey”28

Distinguished Lecture SeriesFor the third consecutive year the College brought prominent speakers to campus as part of itsDistinguished Lecture Series. These lecturers are nominated by the divisions, approved by the Graduateand Research Committee and the Executive Committee, and invited and hosted by the divisions.Dr. Yuichi Sugiyama, Professor of Molecular Pharmacokinetics, University ofTokyo, presented "Drug Transporters in New Drug Discovery and Development,"on Thursday, November 8, 2007. Dr. Sugiyama is the president of both the"International Society for the Study of Xenobiotics (ISSX)" and the "JapaneseSociety for Xenobiotic Metabolism and Disposition (JSSX)”. He is the most-citedauthor in Pharmacology & Toxicology for 1997-2007.Dr. Glen R. Hanson, Professor of Pharmacology and Toxicology, University of Utah,presented "The Neurobiology of Drug Addiction: A Disease Model," on Thursday,March 6, 2008. Dr. Hanson is Director of the Utah Addiction Center and SeniorAdvisor to the National Institute on Drug Abuse. His research aims to elucidate thebasis for neurological and psychiatric disorders, with emphasis on themonoamines and neuropeptides.The Summer Undergraduate Research Fellowship Program Recipients:Undergraduate students, interested in research, discovery, use,or mechanisms of action of drugs/medicines may apply for thissummer fellowship program and earn $4,000 for a ten-week fulltimeexperience. Research activities can be directed by any facultymember in the College of Pharmacy who is willing to mentor astudent for the summer.❖ Damian Hruszkewycz (Chemistry/OSU)❖ Kwan Leung (Pharmaceutical Sciences/OSU)❖ Diamond Ling (Neuroscience/Rochester)❖ Bruce Ware (Pharmaceutical Sciences/OSU)❖ Matthew Welsch (Biochemistry/University of Toledo)❖ Bryan Zorko (Pharmaceutical Sciences/OSU)29

College PublicationsDivision of Medicinal Chemistry and PharmacognosyJ. Hackett, Z. Xiao, X.P. Zang, M.L. Lerner, D.J. Brackett, R.W. Brueggemeier, P.K. Li, and J.T. Pento,Development of keratinocyte growth factor receptor tyrosine kinase inhibitors for the treatment of cancer.Anticancer Res., 27, 3801-3806 (2007).B. Su, E.S. Díaz-Cruz, S. Landini, and R.W. Brueggemeier, Suppression of aromatase expression in human breastcells by novel sulfonanilides occurs via inhibition of intracellular signaling pathways. Steroids, 73, 104-111 (2008).D.D. Davis, E.S. Díaz-Cruz, S. Landini, Y.-W. Kim, and R.W. Brueggemeier, Evaluation of synthetic isoflavoneson cell proliferation, estrogen receptor affinity, and apoptosis in breast cancer cells, J. Steroid Biochem. Molec. Biol.,108, 23-31 (2008).B. Su, R. Tian, M.V. Darby, and R.W. Brueggemeier, Novel sulfonanilide analogs decrease aromatase activity inbreast cancer cells: Synthesis, biological evaluation and pharmacophore identification. J. Med. Chem., 51, 1126-1135 (2008).B. Su, S.M. Mershon, L.A. Stonerock, R.W. Curley, Jr. and R.W. Brueggemeier, 4-Hydroxyphenylretinamide(4HPR) derivatives regulate aromatase activity and expression in breast cancer cells. J. Steroid Biochem. Molec.Biol., 109, 40-46 (2008).B. Su, M.V. Darby, and R.W. Brueggemeier, Synthesis and biological evaluation of novel sulfonanilides asantiproliferative agents for breast cancer. J. Comb Chem., 10, 475-483 (2008).S.C. Weng, Y. Kashida, S.K. Kulp, D. Wang, R.W. Brueggemeier, C.L. Shapiro, and C.S. Chen. Sensitizingestrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derivedphosphoinositide-dependent protein kinase-1/Akt signaling inhibitor. Mol. Cancer Ther., 7, 800-808 (2008).R.W. Brueggemeier, B. Su, Y. Sugimoto, E.S. Díaz-Cruz, and D.D. Davis, Aromatase and COX in breast cancer:Enzyme inhibitors and beyond. J. Steroid Biochem. Molec. Biol., 106, 16-23 (2007).D.D. Miller, R.W. Brueggemeier, and J.T. Dalton, "Adrenocorticoids" in Principles of Medicinal Chemistry, 6thEdition, T.L. Lemke and D.A. Williams, Eds., Williams & Wilkens, Baltimore, 877-912, (2007).D.D. Miller, R.W. Brueggemeier, and J.T. Dalton, "Men’s Health" in Principles of Medicinal Chemistry, 6thEdition, T.L. Lemke and D.A. Williams, Eds., Williams & Wilkens, Baltimore, 1265-1300 (2007).J.-R. Weng, C.-H. Tsai, S. K. Kulp. D. Wang, C.-H. Lin, H.-C. Yang, Y. Ma, A. Sargeant, C.-F. Chiu, M.-H. Tsai,and C.-S. Chen, A potent indole-3-carbinol-derived antitumor agent with pleotropic effects on multiple signalingpathways in prostate cancer cells. Cancer Res, 67, 7815-7824 (2007).Y.-S. Lu, Y. Kashida, S.K. Kulp, J.-H. Hung, D. Wang, Z.-Z. Lin, T.-J. Chen, A.-L. Cheng, and C.-S. Chen,Efficacy of OSU-HDAC42, a novel phenylbutyrate-based histone deacetylase inhibitor, in murine models ofhepatocellular carcinoma. Hepatology, 46, 1119-1130 (2007).M. Sargeant, R.D. Klein, R.C. Rengel, S.K. Clinton, S.K. Kulp, Y. Kashida, M. Yamaguchi, and C.-S. Chen,Chemopreventive and bioenergetic signaling effects of PDK1/Akt pathway inhibition in a transgenic mouse modelof prostate cancer. Toxicol. Pathol., 35, 549-561 (2007).S. Wei, L.-F. Lin, C.-C. Yang, C.-H. Tsai, Y.-C. Wang, G.-D. Chang, H. Chen, and C.-S. Chen,Thiazolidineiones modulate the expression of b-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of SCF E3 ubiquitin ligase independently of PPARg. Mol. Pharmacol., 72, 725-733 (2007).L. M. Porchia, M. Guerra, Y. C. Wang, Y. Zhang, A. V. Espinosa, M. Shinohara, S. K. Kulp, L. S. Kirschner, M.Saji, C.-S. Chen, and M. D. Ringel 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl}acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase. Mol. Pharmacol.,72(5):1124-1131 (2007).B. J. Dewar, O. S. Gardner, C.-S. Chen, H. D. Earp, J. M. Samet, and L. M. Graves Capacitative calcium entrycontributes to the differential transactivation of the epidermal growth factor receptor in response tothiazolidinediones. Mol. Pharmacol., 72:1146-1156 (2007).30

P. Neviani, R. Santhanam, J. J. Oaks, A. M. Eiring, M. Notari, B. W. Blaser, S. Liu, R. Trotta, N. Muthusamy,C. Gambacorti-Passerini, B. J. Druker, J. Cortes, G. Marcucci, C.-S. Chen, N. M. Verrills, D. C. Roy, M. A.Caligiuri, C. D. Bloomfield, J. C. Byrd, and D. Perrotti, FTY720, a new alternative for treating blast crisischronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J. Clin.Invest., 117(9):2408-2421 (2007).Y.-C. Wang, S. K. Kulp, D. Wang, C.-C Yang, A. M. Sargeant, Y. Kashida, M. Yamaguchi, G.-D. Chang, andC.-S. Chen. Targeting ER-stress and Akt signaling with OSU-03012 and gefitinib or erlotinib to overcomeepidermal growth factor receptor inhibitor-resistance in non-small cell lung cancer cells with activated Akt.Cancer Res., 68, 2820-2830 (2008).J.-H. Hung, Y.-S. Lu, Y.-C. Wang, Y.-H. Ma, D. Wang, S. K. Kulp, N. Muthusamy, J. C. Byrd, A.-L. Cheng,and C.-S. Chen FTY720 induces apoptosis in hepatocellular carcinoma cells in part through activation ofreactive oxygen species-protein kinase C-delta signaling. Cancer Res., 68, 1204-1212 (2008).Q. Liu, X. Zhao, F. Frissora, Y. Ma, R. Santhanam, D. Jarjoura, A. Lehman, D. Perrotti, C.-S. Chen, J. T.Dalton, N. Muthusamy, and J.C. Byrd. FTY720 demonstrates promising preclinical activity for chroniclymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood, 111(1):275-284 (2008).J. Yang, S. Wei, D.-S. Wang, Y.-C. Wang, S. K. Kulp, and C.-S. Chen. Pharmacological exploitation of theperoxisome proliferator-activated receptor g agonist ciglitazone to develop a novel class of androgen receptorablativeagents. J. Med. Chem., 51, 2100-2107 (2008).J.-R. Weng, C.-H. Tsai, S. K. Kulp, and C.-S. Chen. Indole-3-carbinol as a chemopreventive and anti-canceragent. Cancer Lett., 262, 153-163 (2008).S.-C. Weng, Y. Kashida, S. K. Kulp. D. Wang, R. W. Brueggemeier, C. L. Shapiro, and C.-S. Chen. Sensitizingestrogen receptor-negative cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived PDK-1/Aktsignaling inhibitor. Mol. Cancer Ther., 7, 800-808 (2008).A.M. Sargeant, R. C. Ringel, S. K. Kulp, R. D. Klein, S. K. Clinton, Y.-C. Wang, and C.-S. Chen. DietaryIntake of OSU-HDAC42, a histone deacetylase inhibitor, blocks prostate tumor progression in the TRAMPmodel. Cancer Res., 68, 3999-4009 (2008).M.A. Park, A. Yacoub, M. Rahmani, G. Zhang, L. Hart, M. P. Hagan, S. K. Calderwood, M. Y. Sherman, C.Koumenis, S. Spiegel, C.-S. Chen, M. Graf, D. T. Curiel, P. B. Fisher, S. Grant and P. Dent. OSU-03012stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression,attenuating its lethal actions in transformed cells. Mol Pharmacol., 73(4):1168-1184 (2008).Anding, A.L., Chapman, J.S., Barnett, D.W., Curley, R.W., Jr., Clagett-Dame, M. The UnhydrolyzableFenretinide Analog 4-Hydroxybenzylretinone Induces the Proapoptotic Genes GADD153 (CHOP) andBBC3(PUMA) and Apoptosis that is Caspase-Dependent and Independent of the Retinoic Acid Receptor.Cancer Res., 67, 6270-6277 (2007).Su, B., Mershon, S.M., Stonerock, L.A., Curley, R.W., Jr., Brueggemeier, R.W. 4-Hydroxyphenylretinamide(4-HPR) Derivatives Regulate Aromatase Activity and Expression in Breast Cancer Cells. J. Steroid Biochem. Mol.Biol., 109, 40-46.Carcache de-Blanco, E. J., Pandit, B., Hu, Z., Shi, J., Lewis, A., Li, P. K. Inhibitors of NF-kappaB derivedfrom thalidomide. Bioorg Med Chem. Lett., 17, (21), 6031-5 (2007).Pento, JT., Li, P.K., Keratinocyte growth factor receptor tyrosine kinase antagonists for the prevention ofmetastatic cancer progression. Drug of the Future, 32(11), 965-72 (2007).Bhasin, D., Cisek, K., Pandharkar, T., Regan, N., Li, C., Pandit, B., Lin, J., Li, P. K. Design, synthesis, andstudies of small molecule STAT3 inhibitors. Bioorg. Med. Chem. Lett., 18, (1), 391-5 (2008).Bandyopadhyaya, A. K., Narayanasamy, S., Barth, R.F., Tjarks, W. Synthesis of novel texaphyrins containinglanthanides and boron; Tetrahedron Lett., 48, 4467-4469 (2007).Tjarks, W., Tiwari, R., Byun, Y., Narayanasamy, S., Barth, R.F., Carboranyl thymidine analogues for neutroncapture therapy; Chem. Commun., 4978-4991 (2007).31

Chandra, S., Tjarks, W., Lorey, D.R., II, Barth, R. F. Quantitative subcellular imaging of boron from BNCTagents in individual mitotic and interphase human glioblastoma cells with SIMS. J. Microsc., 229, 92–103 (2008).Yang, Y., Wu, G., Barth, R.F., Swindall, M.R., Bandyopadhyaya, A.K., Tjarks, W., Tordoff, K., Moeschberger, M.,Sferra, T.J., Binns, P.J., Riley, K.J., Ciesielski, M.J., Fenstermaker, R.A., Wikstrand. C.J., Molecular targeting andtreatment of composite EGFR wildtype and EGFRIII gliomas using boronated monoclonal antibiodies. Clin.Cancer Res., 14, 883-91 (2008).Byun, Y., Vogel, S.R., Phipps, A.J., Carnrot, C., Eriksson, S., Tiwari, R., Tjarks, W., Synthesis and biologicalevaluation of inhibitors of thymidine monophosphate kinase from Bacillus Anthracis. Nucleosides, Nucleotides, andNucleic Acids, 27, 244-260 (2008).Wu, G., Barth, R.F., Yang, W., Lee, R.J., Tjarks, W., Backer, M.V., Joseph M. Backer, J.M. Neutron capturetherapy of cancer: Nanoparticles and high molecular weight boron delivery agents. Nanotechnology for CancerTherapy, Amiji, M.M.Eds, CRC Press, Boca Raton, FL, 77-103 (2007).S. M. Bakunova, S. A. Bakunov, T. Wenzler, T. Barszcz, K. Werbovetz, R. Brun, J. Hall, and R. Tidwell. Synthesisand in vitro antiprotozoal activity of bisbenzofuran cations. J. Med. Chem., 50: 5807-5823 (2007).L. Hu, R. Arafa, M. Ismail, T. Wenzler, R. Brun, M. Munde, W. Wilson, S. Nzimiro, S. Samyesudhas, K.Werbovetz, and D. Boykin. Azaterphenyl diamidines as antileishmanial agents. Bioorg. Med. Chem. Lett., 18: 247-251 (2008).T. George, J. Richard, T. Barszcz, J. Capers and K. Werbovetz. Flavylium salts as precursors of biologically activechalcones. Letters in Drug Design & Discovery, 5: 69-73 (2008).R. Morgan and K. Werbovetz. Selective lead compounds against kinetoplastid tubulin. Advances in ExperimentalMedicine and Biology, 625: 33-47 (2008).S.S. Phifer, D. Lee, E.-K. Seo, N.-C. Kim, T.N. Graf, D.J. Kroll, H.A. Navarro, R.A. Izydone, F.Jiminez, R.Garcia, W.C. Rose, C.R. Fairchild, R. Wild, D.D. Soejarto, N.R. Farnsworth, A.D. Kinghorn, N.H. Oberlies,M.E. Wall, and M.C. Wani, Alvaradoins E-N, new antitumor and cytotoxic anthracenone C-glycosides from theleaves of Alvaradoa haitensis, J. Nat. Prod., 70, 954-961 (2007).G. Murillo, W.H. Hirschelman, A. Ito, R.M. Moriarty, A.D. Kinghorn, J.M. Pezzuto, and R.G. Mehta, Zapotin, aphytochemical present in a Mexican fruit, prevents colon carcinogenesis, Nutr. Cancer, 57, 28-37 (2007).S. Kim, B.Y. Hwang, B.-N. Su, H. Chai, Q. Mi, A.D. Kinghorn, R. Wild, and S.M. Swanson, Silvestrol, apotential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through themitochondrial/apoptosomal pathway without activation of executioner caspase-3 or -7, Anticancer Res., 27, 2175-2184 (2007).A.A. Salim, H.-B. Chai, I. Rachman, S. Riswan, L.B.S. Kardono, N.R. Farnsworth, E.J. Carcache-Blanco, andA.D. Kinghorn, Constituents of the leaves and stem bark of Aglaia foveolata, Tetrahedron, 63, 7926-7934 (2007).Y.-W. Chin, A.D. Kinghorn, and P. Patil, Evaluation of the cholinergic and adrenergic effects of two tropanealkaloids from Erythroxlum pervillei, Phytother. Res., 21, 1002-1005 (2007).Y. Deng, Y.-W. Chin, H. Chai, W.J. Keller, and A.D. Kinghorn, Anthaquinones with quinone reductase-inducingactivity and benzophenones from Morinda citrifolia (noni) fruits, J. Nat. Prod., 70, 2049-2052 (2007).Y.-W. Chin, H.A. Jung, H. Chai, W.J. Keller, and A.D. Kinghorn, Xanthones with quinone reductase-inducingactivity from the fruits of Garcinia mangostana (Mangosteen), Phytochemistry, 69, 754-758 (2008).Y.-W. Chin, A.A. Salim, B.-N. Su, Q. Mi, H.-B. Chai, S. Riswan, L.B.S. Kardono, A. Ruskandi, N.R. Farnsworth,S.M. Swanson, and A.D. Kinghorn Potential anticancer activity of naturally occurring and semi-syntheticderivatives of aculeatins A and B from Amomum aculeatum, J. Nat. Prod., 71, 390-395 (Special issue in honor ofDr. G. Robert Pettit), (2008).A.D. Kinghorn, “Drug discovery from natural products”, in Foye’s Principles of Medicinal Chemistry, 6th Edition, T.Lemke and D.A. Williams, Eds. J Wolters Kluwer/Lippincott Willliams & Wilkins, Philadelphia, PA, pp. 12-25(2008).32

M. Bahar, Y. Deng, J.N. Fletcher, and A.D. Kinghorn, “Plant-derived natural products in drug discoveryand development: an overview, in Selected Topics in the Chemistry of Natural Products, R. Ikan, Ed. World ScientificPublications, Singapore, pp. 11-48 (2008).A.A. Salim, Y.-W. Chin, and A.D. Kinghorn, “Drug discovery from plants”, in Bioactive Molecules and MedicinalPlants, K. Ramawat and J.M. Merillon, Eds. Springer-Verlag, Heidelberg, pp. 1-24 (2008).Ding, H., Y.-W. Chin, A.D. Kinghorn, and S. D’Ambrosio, Chemopreventive characteristics of avocado fruit,Sem. Cancer Biol., 17, 386-394 (2007).Pawlus, A.D. and A.D. Kinghorn, Review of the ethnobotany, chemistry, biological activity and safety of thebotanical dietary supplement Morinda citrifolia (noni), J. Pharm. Pharmacol., 59, 1587-1609 (2007).Bhasin, D., Cisek, K., Pandharkar, T., Li, C., Lin, J. and Li, P.-K. Design, synthesis and studies of small moleculeSTAT3 inhibitors, Bioorg. Medicinal. Chem. Lett., 18, 391-395 (2008).Patil, P. N.;Li, C.; Kumari, V. and Hieble, J. P. “Analysis of efficacy of chiral adrenergic agonists”. Chirality, 20,529-543 (2008).George, T. G.; Endeshaw, M. M.; Morgan, R. E.; Mahasenan, K. V.; Delfín, D. A.; Mukherjee, M. S.; Yakovich, A.J.; Li, C. and Werbovetz, K. A. Synthesis, biological evaluation and molecular modeling of 3,5-substituted-N1-phenyl-N4, N4-di-n-butylsulfanilamides as antikinetoplastid antimicrotubule agents. Bioorg. Medicinal. Chem.,15(18), 6071-6079 (2007).Salim AA, Chai H-B, Rachman I, Riswan S, Kardono LBS, Farnsworth NR, Carcache-Blanco EJ, Kinghorn AD.Constituents of the leaves and stem bark of Aglaia foveolata. Tetrahedron, 63:7926-7934 (2007).Kim JA, Tay D, Carcache-Blanco EJ. NF-kB inhibitory activity of compounds isolated from Cantharelluscibarius. Phytopher. Res., 22:1104-1106 (2008).Division of PharmaceuticsHu, L., Au, J.L., and Wientjes, M.G. Computational modeling to predict effect of treatment schedule on drugdelivery to prostate in humans. Clin. Cancer Res, 13:1278-1287 (2007).Lu, D., Wientjes, M.G., Lu, Z., and Au, J.L. Tumor priming enhances delivery and efficacy of nanomedicines.J. Pharmacol. Exp. Ther., 322:80-88 (2007).Tsai, M., Lu, Z., Wang, J., Yeh, T.K., Wientjes, M.G., and Au, J.L. Effects of carrier on disposition and antitumoractivity of intraperitoneal Paclitaxel. Pharm. Res, 24:1691-1701 (2007).Ortiz, R., Au, J.L.-S., Lu, Z., Gan, Y. and Wientjes, M.G. Biodegradable intraprostatic doxorubicin implants.AAPS J., 9:E241-E250 (2007).Shen, Z., Shen, T., Wientjes, M.G., O'Donnell, M.A., and Au, J. L. Intravesical treatments of bladder cancer:review. Pharm. Res., 25 (7):1500-1510 (2008).Liu Z, Fan-Havard P, Xie Z, Chen Ren, and Chan KK. A Liquid Chromatography/atmospheric PressureIonization Tandem Mass Spectrometry Quantitation Method for Nevirapine and its Two Oxidative Metabolites, 2-hydroxynevirapine and Nevirapine 4-carboxylic Acid, and Pharmacokinetics in Baboons. Rapid Communications inMass Spectrometry, 21(16): 2734-2742 (2007).Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, Liu S, Alder H, Costinean S, Fernandez-Cymering C, Volinia S, Guler G, Morrison CD, Chan KK, Marcucci G, Calin GA, Huebner K and Croce CM*.MicroRNA-29 Family Reverts Aberrant Methylation in Lung Cancer by Targeting DNA Methyltransferases 3Aand 3B. PNAS, 104(40) 15805-15810 (2007).Eyles A, Jones W, Riedl K, Cipollini D, Schwartz S, Chan K, Herms DA, and Bonello P. Comparative PhloemChemistry of Manchurian (Fraxinus mandshurica) and Two North American Ash Species (Fraxinus americana andFraxinus pennslvanica). J. Chem. Ecol., 33:1430-1448 (2007).33

34Liu S, Liu Z, Xie Z, Pang J, Yu J, Lehmann E, Huynh L, Vukosavljevic T, Takeki M, Klisovic RB, Baiocchi RA,Blum W, Porcu P, Garzon R, Byrd JC, Perrotti D, Caligiuri MA, Chan KK, Wu L-C, and Marcucci G.Bortezomib Induces DNA Hypomethylation and Silenced Gene Transcription by Interfering with Sp1/NF-kBdependentDNA Methylatransferase Activity in Acute Myeloid Leukemia. Blood, prepublished on-line DOI10.1182/blood-2007-08-110171, 111(4): 2364-2373 (2008).Bekaii-Saab, TS, Liu J, Chan KK, Balcerzak SP, Ivy PS, Grever MR, and Kraut EH. A Phase I andPharmacokinetic Study of Weekly Oxaliplatin Followed by Paclitaxel in Patients with Solid Tumors. Clin. CancerRes., 14(11): 3434-3440 (2008).Klisovic, RB, Blum, W, Wei, X, Liu, S, Liu, Z, Xie, Z, Vukosavljevic, T, Kefauver, C, Huynh, L, Pang J, Zweibel,JA, Devine, S, Byrd, JC, Grever, MR, Chan, K, and Marcucci, G. Phase 1 Study of GTI-2040, an Antisense toRibonucleotide Reductase, in Combination with High-Dose Cytarabine in Patients with Acute Myeloid Leukemia.Clin. Cancer Res., 14(12): 3889-3895 (2008).Kim J, Bronson CL, Wani MA, Oberyszyn TM, Mohanty S, Chaudhury C, Hayton WL, Robinson JM, andAnderson CL. β2-microglobulin deficient mice catabolize IgG more rapidly than FcRn-α-chain deficient mice.Exp. Biol. Med., 233:603-609 (2008).W.L. Hayton, and T. M. Hu. Allometric Scaling. Chapter 29 in Preclinical Development Handbook: ADME andBiopharmaceutical Properties, S.C Gad, Ed., John Wiley and Sons (2008) pp. 1009-1035.K.M. Kleinow, J.W. Nichols, W.L. Hayton, J.M. McKim, M.G. Barron. Toxicokinetics in Fishes, Chapter 3 inThe Toxicology of Fishes, R.T. Di Giulio and D.E. Hinton, Eds., CRC Press Taylor & Francis Grouppp. 55-152(2008).Datta SA, Zhao Z, Clark PK, Tarasov S, Alexandratos JN, Campbell SJ, Kvaratskhelia M, Lebowitz J, Rein AR(2007) Interactions between HIV-1 Gag molecules in solution: An inositol phosphate-mediated switch. J. Mol.Biol., 365(3):799-811.Deval J, D’Abramo CM, Zhao Z, McCormick S, Coutsinos D, Hess S, Kvaratskhelia M, Götte M (2007) Highresolution footprinting of the hepatitis C virus polymerase NS5B in complex with RNA. J. Biol. Chem.,282:16907-16.Bradley CM, Jones S, Huang Y, Suzuki Y, Kvaratskhelia M, Hickman AB, Dyda, F. Structural Basis forDimerization of LAP2α, a Component of the Nuclear Lamina, Structure, 15:643-53 (2007) .Zhao Z, McKee CJ, Kessl JJ, Santos WL, Daigle JE, Engelman A, Verdine G, Kvaratskhelia M, Subunit specificprotein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1integrase during viral DNA binding. J. Biol. Chem., 283:5632-41 (2008).Zhao, X.B., Muthusamy, N., Byrd, J.C., and Lee, R.J. Cholesterol as a bilayer anchor for PEGylation and targetingligand in folate-receptor-targeted liposomes. J. Pharm. Sci., 96:2424-2435 (2007).Zhao, X.B., Lapalombella, R., Joshi, T., Cheney, C., Gowda, A. Ledbetter, M. H., Baum, P., Lin, T., Jarjoura, D.,Lehman, A., Lee, R.J., Caligiuri, M.A., Tidandapani, S., Muthusamy, N., Byrd, J.C. Targeting CD37+ lymphoidmalignancies with a novel engineered small modular immunopharmaceutical, Blood, 110: 2569 – 2577 (2007).Fulci, G., Dmitrieva, N., Gianni, D., Fontana, E.J., Pan, X., Lu, Y., Kaufman, C.S., Kaur, B., Lawler, S.E., Lee,R.J., Marsh, C.B., Brat, D.J. van Rooijen, N., Rachamimov, A.S., Hochberg, F.H., Weissleder, R., Martuza, R.L.and Chiocca, E.A. Depletion of Peripheral Macrophages and Brain Microglia Increases Brain Tumor Titers ofOncolytic Viruses. Cancer Res., 67: 9398-9406 (2007).Weecharangsan W., Opanasopit P., Ngawhirunpat T., Apirakaramwong A., Rojanarata T., Ruktanonchai U., andLee R.J., Evaluation of chitosan salts as nonviral gene vectors in CHO-K1 cells, Int. J. Pharm, 348:161-168(2008).Zhao, X.B., Wu, J., Muthusamy, N., Byrd, J.C., and Lee, R.J. Liposomal Co-encapsulated Fludarabine andMitoxantrone for Lymphoproliferative Disorder Treatment. J. Pharm. Sci., 97:1508-1518 (2008).Lapalombella, R., Zhao, X., , N., Yu, B., Jin, Y., Lozanski, G., Cheney, C., Jarjoura, D., Lehman, A., Lee, L.J.,Marcucci, G., Lee, R.J., Caligiuri, M.A., Muthusamy, N., and Byrd, J.C. A novel Raji-Burkitt’s lymphoma modelfor preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents. Clin. Cancer Res., 14:569-578 (2008).

Weecharangsan W., Opanasopit P. and Lee R.J., Effect of depsipeptide on in vitro transfection efficiencyof PEI/DNA complexes. Anticancer Res., 28:793-798.Pan, X., Guan, J., Yoo, J.-W., Epstein, A.J., Lee, L.J., and Lee, R.J. Cationic Lipid-Coated MagneticNanoparticles Associated with Transferrin for Gene Delivery. Int. J. Pharm., 358:263-270 (2008).Pradhan, P., Guan, J., Lu, D., Wang, PG, Lee, LJ, and Lee, RJ. A Facile Microfluidic Method for Production ofLiposomes, Anticancer Res., 28:943-948 (2008).Xiang, G., Wu, J., Lu, Y., Liu, Z., and Lee, R.J. Synthesis and Evaluation of a Novel Ligand for Folate-MediatedTargeting of Liposomes, Int. J. Pharm., 356: 29–36 (2007).J. Guan, X. Pan, L. J. Lee, R.J. Lee. Viral, Non-Viral, and Physical Methods for Gene Delivery, inBiopharmaceutical Drug Design and Development, 2nd Edition, Ed. S. Wu-Pong and Y. Rojanasakul, HumanaPress, 141-174 (2008).Zhao, X., Li, H., and Lee, R.J. Targeted drug delivery via folate receptors, Expert Opinion in Drug Delivery,5(3):1-11 (2008).Lee RJ. Modern Drug Discrovery and Development- GTCbio’s Third Annual Summit conference report,IDrugs, 11(2):101-104 (2008).Foraker, A.B., Ray, A., Da Silva, C., Bareford, L.M., Hillgren, K.M., Schmittgen, T.D., and Swaan, P.W.Dynamin 2 regulates riboflavin endocytosis in human placental trophoblasts. Molec. Pharmacol., 72:553-562(2007).Martin, M.M., Buckenberger, J.A., Jiang, J., Malana, G.E., Feldman, D.S., Schmittgen, T.D., and Elton, T.S.The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates miR-155 binding. J. Biol.Chem., 282:24262-9 (2007).Calin, G.A., Liu, C.G., Ferracin, M., Hyslop, T., Sevignani, C., Cimmino, A., Wojcick, S.,Shimizu, M., Fabbri,M., Picchiori, F., Lee, E.J., Liu, X., Volta, C., Zuppo, S., Herlea, V., Gramantieri, L., Lanza, G., Alder, H.,Schmittgen, T.D., Volinia, S., Rassenti, L., Kipps, T.J., Negrini, M. and Croce, C.M. Ultraconserved regionsencoding noncoding RNAs are altered in human leukemias and carcinomas. Cancer Cell, 12:215-229 (2007).Gusev, Y., Schmittgen, T.D., Lerner, M.R., Postier, R.G. and Brackett, D.J. Computational analysis of biologicalfunctions and pathways collectively targeted by co-expressed microRNAs in cancer. BMC Bioinformatics, 8(Suppl7): S16 (2007).Lee, E.J., Baek, M., Nuovo, G.J., Chen, C. and Schmittgen, T.D. Systematic evaluation of microRNAprocessing patterns in tissues, cell lines and tumors. RNA, 14:35-42 (2007).Blower, P.E., Chung, J.H., Verducci, J.L., Lin, S., Park, J. K., Dai1, Z., Liu, C.G., Schmittgen, T.D., Croce,C.M., Weinstein, J.N., and Sadee, W. MicroRNAs Modulate Chemoresistance of Tumor Cells. Molec. CancerTher., 7: 1-9 (2008).Jiang, J., Aderca, I., Gusev, Y., Mettler, T.A., Nagorney, D.M., Brackett, D.J., Roberts, L.R. and Schmittgen,T.D. microRNA expression in hepatocellular carcinoma is associatedwith hepatitis infection, cirrhosis andpatient’s survival. Clin. Cancer Res., 14: 419-427 (2008).Kuhn, D.E., Nuovo, G.J., Martin, M.M., Malana, G.E., Pleister, A.P., Jiang, J., Schmittgen, T.D., Terry, A.V. Jr,Gardiner, K., Head, E., Feldman, D.S., Elton, T.S. Human chromosome 21-derived miRNAs are overexpressedin down syndrome brains and hearts. Biochem Biophys. Res. Commun., 370:473-477 (2008).Hackanson, B., Bennett, K.L., Brena, R.M., Jiang, J., Maharry, K., Whitman, S.P., Schmittgen, T.D., Lübbert,M., Marcucci, G., Bloomfield, C.D. and Plass, C. Reactivation of epigenetically down-regulated microRNA-124a silences the hematopoietic transcription factor C/EBPα in acute myeloid leukemia. Cancer Res., 68:3142-3151 (2008).Barbarotto, E., Schmittgen, T.D. and Calin, G.A. microRNAs and cancer: Profile, Profile, Profile. Int. J. Cancer,122:969-977 (2007).Schmittgen, T.D., E.J. Lee, and J. Jiang, High-throughput real-time PCR, in Molecular Beacons: SignalingNucleic Acid Probes, Methods and Protocols, A. Marx and O. Seitz, Editors, Humana Press: Totowa, NJ. pp. 89-98(2008).35

Schmittgen, T.D., Lee, E.J., Jiang, J., Yang, L., Elton, T.S. and Chen, C. Real-time PCR quantification ofprecursor and mature microRNA. Methods, 44:31-38 (2008).Schmittgen, T.D., and Livak, K.J. Analyzing real-time PCR data by the comparative CT method. Nature Protocols,3:1101-1108 (2008).Tao Zhang, Adel Hamza, Xianhua Cao, Bing Wang, Shuwen Yu, Chang-Guo Zhan, Duxin Sun. A Novel Hsp90inhibitor disrupts Hsp90-Cdc37 complex for pancreatic cancer therapy. Molecular Cancer Therapeutics, 7 (2008).Xianhua Cao, Mark Bloomston, Guang Jia, Wendy L. Frankel, Tao Zhang, Nathan Hall, Hao Cheng, MichaelKnopp, and Duxin Sun. Simultaneously Targeting Hypoxic Cancer Cells by HSP90 Inhibitor and GlycolysisInhibitor in Pancreatic Cancer Therapy. Clinical Cancer Research, 14: 1831 (2008).Xianhua Cao, Bing Wang, Guang Jia, Ming Yang, Michael V. Knopp and Duxin Sun. Non-invasive tumor MRIimaging and synergistic anti-tumor effect of HSP90 inhibitor and glycolysis inhibitor in RIP1-Tag2 transgenicpancreatic tumor model. Cancer Chemotherapy and Pharmacology, (2008).Huifei Cui, Jie Shen, Dongning Lu, Tao Zhang, Wenpeng Zhang, Duxin Sun, Peng George Wang. 4-Aryl-1,3,2-oxathiazolylium-5-olate: A novel GST Inhibitor to release JNK and activate c-Jun for cancer therapy. CancerChemotherapy and Pharmacology, (2008).Duxin Sun, Mark Bloomston, George Hinkle, Osama Habib Al-Saif, Nathan C. Hall, Stephen P. Povoski, MarkW. Arnold, Edward W. Martin Jr. Radioimmunoguided Surgery (RIGS), PET/CT Image-Guided Surgery, andFluorescence Image-Guided Surgery: Past, Present, and Future. Journal Surgical Oncology, 96: 297 (2007).Xianhua Cao and Duxin Sun. Drug Absorption Principles. Biopharmaceutics Applications in Drug DevelopmentSpringer Science Business Media, Inc., New York, NY (2007).Division of Pharmacology36Kuhn, D.E., Nuovo, G.J., Martin, M.M., Malana, G.E., Pleister, A.P., Jiang, J., Schmittgen, T.D., Terry, A.V., Jr.,Gardiner, K., Head, E., Feldman, D.S., Elton, T.S. "Human chromosome 21-derived miRNAs are overexpressed indown syndrome brains and hearts". Biochem Biophys Res Commun. Jun 6; 370(3): 473-7 (2008).Kuhn, D.E., Martin, M.M., Feldman, D.S., Terry, A.V., Jr., Nuovo, G.J., Elton, T.S. "Experimental validation ofmiRNA targets". Methods. 44(1):47-54 (2008).Schmittgen, T.D., Lee, E.J., Jiang, J., Sarkar, A., Yang, L., Elton, T.S., Chen, C. "Real-time PCR quantification ofprecursor and mature microRNA". Methods. Jan; 44(1): 31-8 (2008).Martin, M.M., Buckenberger, J.A., Jiang, J., Malana, G.E., Knoell, D.L., Feldman, D.S., Elton, T.S. "TGF-beta1stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK,AND P13K signaling pathways". Am. J. Physiol. Lung Cell Mol. Physiol. 293(3): L790-9 (2008).Martin, M.M., Buckenberger, J.A., Jiang, J., Malana, G.E., Nuovo, G.J., Chotani, M., Feldman, D.S.,Schmittgen, T.D., Elton, T.S. "The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuatesmicrorna-155 binding". J. Biol. Chem. 282(33): 24262-9 (2007).Sethupathy, P., Borel, C., Gagnebin, M., Grant, G.R., Deutsch, S., Elton, T.S., Hatzigeorgiou, A.G., and S.E.Antonarakis. "Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target inthe AGTR1 3 untranslated region: a mechanism for functional single-nucleotide polymorphisms related tophenotypes". Am. J. Hum. Genet. 81:405-13 (2007).Feldman, D.S., Elton, T.S., Sun, B., Martin, M.M., and Ziolo, M.T. Mechanisms of disease: detrimentaladrenergic signaling in acute decompensated heart failure. Nat. Clin. Pract. Cardiovasc Med. 5(4): 208-18 (2008).Huang, H., Liu, T., Rose, J.L., Stevens, R.L., Hoyt, D.G. "Sensitivity of mice to lipopolysaccharide is increased bya high saturated fat and cholesterol diet". J. Inflamm. (Lond). Nov. 12; 4(1): 22 (2007).Ma, T.C., Mihm, M.J., Bauer, J.A., Hoyt, K.R. "Bioenergetic and oxidative effects of free 3-nitrotyrosine inculture: selective vulnerability of dopaminergic neurons and increased sensitivity of non-dopaminergic neurons todopamine oxidation". J. Neurochem. 103(1): 131-44 (2007).

Choi Y.S., Cho H.Y., Hoyt K.R., Naegele, J.R., Obrietan, K. "IGF-1 receptor-mediated ERK/MAPKsignaling couples status epilepticus to progenitor cell proliferation in the subgranular layer of the dentategyrus". Glia. 56: 791-800 (2008).Jiao, J., Garg, V., Yang, B., Hu, K. "Novel functional role of heat shock protein 90 in ATP-sensitive K+channel-mediated hypoxic preconditioning". Cardiovasc Res., Jan; 77(1): 126-33 (2008).Garg, V., Hu, K. "Protein kinase C isoform-dependent modulation of ATP-sensitive K+ channels inmitochondrial inner membrane". Am. J. Physiol. Heart Circ. Physiol. 293(1):H322-32 (2007).Shah, V.B., Huang, Y., Keshwara, R., Ozment-Skelton, T., Williams, D.L., Keshvara, L. "Beta-glucan activatesmicroglia without inducing cytokine production in Dectin-1-dependent manner". J. Immunol., Mar., 180(5):2777-85 (2008).Huang, J., Orac C.M., McKay, S., McKay, D.B., and Bergmeier, S.C. "The synthesis of 5-substituted ring Eanalogs of methyllycaconitine via the Suzuki-Miyaura cross-coupling reaction". Bioorg. Mel. Chem., 16(7):3816-24 (2008).El-Hajj, R.A., McKay, S.B., and McKay, D.B. "Pharmacological and immunological identification of nativeα7 nicotinic receptors: evidence for homomeric and heteromeric α7 receptors". Life Sci., 81(16): 1317-22(2007).Chin, Y.W., Kinghorn, A.D., Patil, P.N. "Evaluation of the cholinergic and adrenergic effects of two tropanealkaloids from Erthroxylum pervillei". Phytother Res., 21(10): 1002-5 (2007).Goseki, T., Shimizu, K., Ishikawa, H., Nishimoto, H., Uga, S., Nemoto, N., Patil, P.N. "Possible mechanismof intraoperative floppy iris syndrome: a clinicopathological study". Br. J. Opthmol., 16:23:14 (2008).Patil, P.N., Li, C., Kumari, V., Hieble, J.P. "Analysis of efficacy of chiral adrenergic agonists". Chirality. Mar;20(3-4): 529-43. Erratum in: Chirality. Jun; 20(6): 813-4 (2008).Joshi, M.S., Bauer, J.A., Werbovetz, K.A., Barszcz, T., Patil, P.N. "Pharmacological and biological screening ofascorbigen". Phytoth Res., (in press) (2008).Wallace, L.J., Connell, L.E. "Mechanisms by which amphetamine redistributes dopamine out of vesicles: acomputational study". Synapse., 62(5): 370-8 (2008).Wallace L.J. "A small dopamine permeability of storage vesicle membranes and end product inhibition oftyrosine hydroxylase are sufficient to explain changes occurring in dopamine synthesis and storage afterinhibition of neuron firing". Synapse, 61(9): 715-23 (2007).Division of Pharmacy Practice and AdministrationConde JF, Yelverton CB, Balkrishnan R, Fleischer AB Jr, Feldman SR. Managing rosacea: a review of the useof metronidazole alone and in combination with oral antibiotics. Journal of Drugs in Dermatology – 6(5):495-498 (2007).Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R. Adherence to topical therapyincreases around the time of office visits. Journal of the American Academy of Dermatology – 57(1): 81-83(2007).McMichael AJ, Wasserman DI, Pearce DJ, Camacho FT, Fleischer AB, Feldman SR, Balkrishnan R. AlopeciaAreata: Outpatient Utilization and Common Prescribing Patterns in the United States. Journal of the AmericanAcademy of Dermatology – 57(2): s49-s51 (2007).Rasu RS, Manley H, Crawford T, Balkrishnan R. Undertreatment of Anemia in patients with Chronic KidneyDisease in the United States: Analysis of the U.S. National Ambulatory Medical Care Survey ClinicalTherapeutics – 29(7): 1524-1534 (2007).Pawaskar MD, Anderson RT, Balkrishnan R. Self-Reported Predictors of Depressive Symptomatology in anElderly Population with Type 2 Diabetes Mellitus: A Prospective Cohort Study. Health and Quality of LifeOutcomes – 5(1): 50 (2007).37

Pawaskar MD, Satiani B, Balkrishnan R, Starr JE. Economic Evaluation of Carotid Angioplasty and Stentingversus Carotid Endarterectomy for the Treatment of Carotid Artery Stenosis: A Provider’s Perspective. Journal ofthe American College of Surgeons – 205(3): 413-419 (2007).Jayawant SS, Bhosle MJ, Anderson RT, Balkrishnan R. Depressive symptomatology, medication persistence, andassociated health care costs in older adults with glaucoma. Journal of Glaucoma – 16(6): 513-520 (2007).Jayawant SS, Camacho FT, Anderson RT, Balkrishnan R. Does the use of Thiozolidinediones in older adults withType 2 diabetes Improve Outcomes? A Database Analysis. Drug Benefit Trends – 19(Supplement B): 22-32 (2007).Fosse K, Kurtz E, Khanna V, Camacho F, Balkrishnan R, Feldman SR. A practice brochure is a complement to,not a supplement for, a good physician-patient interaction. (Research Letter). Archives of Dermatology – 143(11):1447 (2007).Kong MC, Camacho FT, Feldman SR, Anderson RT, Balkrishnan R. Correlates of patient satisfaction withphysician visits: Differences between elderly and non-elderly survey respondents. Health and Quality of LifeOutcomes – 5(1): 62, 6 printed pages, online publication (2007).Satyaprakash A, Balkrishnan R, Camacho FT, Jayawant SS, Fleischer AB, Feldman SR. Quality of dermatologiccare delivered by physician assistants: An analysis of clotrimazole/betamethasone propionate prescriptions.(Research Letter). Archives of Dermatology – 143(12):1591-1592 (2007).Pawaskar MD, Joish VN, Camacho FT, Rasu RS, Balkrishnan R. The Influence Of Comorbidities OnPrescribing Pharmacotherapy For Insomnia: Evidence From US National Outpatient Data 1995-2004. Journal ofMedical Economics – 11(1): 41-56 (2008).Shenolikar RA, Balkrishnan R. Oral antidiabetic medication adherence and associated healthcare utilizationamong Medicaid-enrolled type 2 diabetes patients newly starting monotherapy. Diabetes Care – 31(2): e5 (2008).Kulkarni AS, Balkrishnan R, Kirsch J, Edin HM, Anderson RT, Stacy MS. Medication Adherence and AssociatedOutcomes in Medicare HMO-enrolled older adults with Parkinsons Disease: A longitudinal cohort study.Movement Disorders – 23(3): 359-365 (2008).Navaratnam P, Jayawant SS, Pedersen CA, Balkrishnan R. Physician adherence to the national asthma prescribingguidelines: Evidence from national outpatient survey data in the United States. Annals of Allergy, Asthma &Immunology – 100(3): 216-221 (2008).Uhas AA, Camacho FT, Feldman SR, Balkrishnan R. The relationship between physician empathy andsatisfaction with primary care physicians: Findings from an internet based survey. The Patient – 1(2): 91-96(2008).Pawaskar MD, Balkrishnan R, Kiser D, Gray M, Satiani B. Work Flow Analysis: Evaluation of ConventionalMobile Vs Portable Ultrasound Scanners in Noninvasive Vascular Laboratory. Journal of Vascular Ultrasound –32(2): 85-88 (2008).Bhosle MJ, Feldman SR, Camacho FT, Fleischer AB, Balkrishnan R. Prescribing Patterns for Topical Retinoids:Analyses of 15 years data from the National Ambulatory Medical Care Survey. Managed Care Interface – 20(2): 27-30 (2008).Garduno J, Bhosle MJ, Balkrishnan R, Feldman SR. Measures Used in Specifying Psoriasis Lesion(s), GlobalDisease & Quality of Life: A Systematic Review. Journal of Dermatological Treatment – 18(4): 223-242 (2007).Rasu RS, Crawford T, Manley HJ, Balkrishnan R. Treatment of hypertension and diabetes mellitus in patientswith chronic kidney disease: a review Expert Opinion on Pharmacotherapy – 8(15): 2543-2551 (2007).Rasu RS, Crawford T, Manley HJ, Balkrishnan R. Treatment and costs associated with anemic chronic kidneydisease patients. Current Medical Research and Opinion – 24(1): 129-137 (2008).Nelson AA, Pearce DJ, Fleischer AB, Balkrishnan R, Feldman SR. Cost-effectiveness of biologic treatments forpsoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. Journal ofthe American Academy of Dermatology – 58(1): 125-135 (2008).38

Iaconi A, Zimmerman MA, Kulkarni AS, Balkrishnan R. Outcomes Associated with PharmacologicalTreatments in Parkinson’s Disease: A Review of the Recent Literature. Expert Opinion on Pharmacotherapy – 9(2):163-174 (2008).Inglese MJ, Fleischer AB, Feldman SR, Balkrishnan R. The Pharmacoeconomics of Acne Treatment: Where arewe heading? Journal of Dermatological Treatment – 19(1): 27-37 (2008).Pearce DJ, Williford PM, Balkrishnan R, Feldman SR. The Economics of Skin Cancer. Chapter 61. in SkinCancer (Edited by Keyvan Nouri ) Pages 679-686. McGraw Hill, New York, NY, 2007. ISBN: 0071472568Ali SM, Brodell RT, Balkrishnan R, Feldman SR. Poor Adherence to Treatments: A Fundamental Principle ofDermatology. Archives of Dermatology – 143(7): 912-915 (2007).Awadalla FC, Yentzer B, Balkrishnan R, Feldman SR.A role for denial in poor adherence to psoriasis treatment.Journal of Dermatological Treatment, 18(6):324-325 (2007).Dawn AG, Balkrishnan R, Feldman SR. Systematic Selection Bias: A Cause of Dramatic Errors in Inference ofTreatment Effectiveness. Journal of Dermatological Treatment – 19(2): 68-71 (2008).Awadalla FC, Balkrishnan R, Feldman SR. The distress of psoriasis doesn’t necessarily imply good treatmentadherence: A lesson from the treatment of sexually transmitted disease. Journal of Dermatological Treatment – 19(3):132-133 (2008).Bennett MS, Smith GH, Patterson BJ. Unprecedented Collaboration Among Academies as Profession, APhA areon the Cusp of Greatness. JAPhA 48:2;116-137Ried LD, Bennett MS, Smith GH. Practice-based research Networks: Keeping the Highway Running through thePharmacy Community JAPhA 48:2;138-141Buffington DE, Bennett MS. Documenting Patient Care Services. Medication Therapy Management ServicesModule 5 APhA November 2007, Chronic Diseases, in: Knutson, Douglas. Family Medicine: Pre-Test, Self-Assessment, and Review. First Edition. McGraw-Hill (2008).Brackett, CA, Chronic Diseases, in: Knutson, Douglas. Family Medicine: Pre-Test, Self-Assessment, and Review.First Edition. McGraw-Hill (2008).Buerki RA, Vottero LD. Foundations of Ethical Pharmacy Practice. Madison, WI: American Institute of the Historyof Pharmacy, viii + 57 pp(2008).Kelley KA, Coyle JD, McAuley JW, Wallace LJ,Buerki RA, Frank SG. Writing program-level, ability-basedoutcomes: key elements for success. Am. J. Pharm. Ed. (5), Article 98 (2008).Flannery MA, Buerki RA, Higby GH. Continuing education: 150 years of American pharmacy as reflected in itstrade press. Drug Topics, 151:10, 55-60 (2007).Salim AA, Chai H-B, Rachman I, Riswan S, Kardono LBS, Farnsworth NR, Carcache-Blanco EJ, Kinghorn AD.Constituents of the leaves and stem bark of Aglaia foveolata. Tetrahedron, 63:7926-7934 (2007).Lacombe VA, Viatchenko-Karpinski S, Terentyev D, Sridhar A, Emani S, Bonagura JD, Feldman DS, Gyorke S,Carnes CA. Mechanisms of impaired calcium handling underlying subclinical diastolic dysfunction in diabetes.Am. J. Physiol. Regul. Integr. Comp. Physiol., 293(5): R1787-97 (2007).Belevych A, Kubalova Z, Terentyev D, Hamlin RL, Carnes CA, Gyorke S. Enhanced Ryanodine Receptor-Mediated Calcium Leak Determines Reduced Sarcoplasmic Reticulum Calcium Content in Chronic Canine HeartFailure. Biophys. J., 11:4083-92 (2007).Holycross BJ, Kukielka M, Nishijima Y, Altschuld RA, Carnes CA, Billman GE. Exercise Training Normalizes{beta}-adrenoceptor Expression in Dogs Susceptible to Ventricular Fibrillation. Am. J. Physiol. Heart Circ. Physiol.,293: H2702-9 (2007).Nishijima Y,Sridhar A, Viatchenko-Karpinski S, Shaw C, Bonagura JD, Abraham WT , Joshi MS, Bauer JA,Hamlin RL, Györke S, Feldman DS, Carnes CA. Chronic cardiac resynchronization therapy and reverseventricular remodeling in a model of nonischemic cardiomyopathy. Life Sci., 81:1152-9 (2007).39

Carnes CA, Janssen PML, Ruehr ML Nakayama H, Nakayama T, Haase H, Bauer JA, Chung MK, Fearon IM,Gillinov M, Hamlin RL, Van Wagoner DR., Atrial glutathione content, calcium current and contractility. J. Biol.Chem., 282(38):28063-28073 (2007).Mandal R, Kutala VK, Khan M, Mohan IK, Varadharaj S, Sridhar A, Carnes CA, Kálai T, Hideg K, KuppusamyK. A Pro-nitroxyl Modification of Verapamil Exhibits Antioxidant Protection of Heart againstIschemia/Reperfusion-induced Cardiac Dysfunction without compromising Calcium Antagonistic Activity, J.Pharm. Exp. Ther., 323: 119-127 (2007).Sridhar A, da Cunha DNQ, Lacombe VA, Zhou Q, Fox JJ, Hamlin RL, Carnes CA. 4-Aminopyridine-SensitivePlateau Outward Current in Canine Ventricle: A Constitutive Contributor to Ventricular Repolarization, Br. J.Pharmacol., 152:870-9 (2007).Babu GJ, Bhupathy P, Carnes CA, Billman GE, Periasamy M..Differential expression of sarcolipin protein duringmuscle development and cardiac pathophysiology, J. Mol. Cell. Cardiol., 43:215-22 (2007).Dirksen WP, Lacombe VA, Chi M, Kalyanasundaram A, Viatchenko-Karpinski S, Terentyev D, Carnes CA,Chiamvimonvat N, Gyorke S., Periasamy M. A mutation in calsequestrin CSQD307H impairs SR calciumstorage and release functions and causes polymorphic ventricular tachycardia in mice. Cardiovasc. Res., 75:69-78(2007).Lindstrom NR, Casper KA, Green TR, Pedersen CA. Designing pharmacy services based on grocery store patronpreferences. J. Am. Pharm. Assoc., 47:605-12 (2007).Casper KA. OTC Product: Align. J. Am. Pharm. Assoc., 47:e10-11 (2007).Clark CA, Mehta BH, Rodis JL, Pruchnicki MC, Pedersen CA. Assessment of Factors Influencing CommunityPharmacy Residents’ Pursuit of Academic Positions. Am. J. Pharm. Educ., 72(1): Article 03 (2008).Coyle JD and Joy MS. Chapter 52: “Disorders of Sodium and Water Balance” in Pharmacotherapy: APathophysiologic Approach, 7th ed., DiPiro JT et al. (eds), McGraw-Hill, New York, June (2008).Sun D, Bloomston M, Hinkle G, Al-Saif OH, Hall NC, Povoski SP, Arnold MW, Martin Jr. EW.Radioimmunoguided Surgery (RIGS), PET/CT Image-Guided Surgery and Fluorescence Image-Guided Surgery:Past, Present and Future. J. Surg. Oncol., 96:297-308 (2007).Dura JV, Hinkle GH. Stability of Technetium Tc-99m Sulfur Colloid and Lidocaine Mixture. Am. J. Health-Syst.Pharm., 64:2477-2479 (2007).Schultz MK, Cessna JT, Anderson TL, Ponto JA, Petry N, Kowalsky RJ, Palmer MR, Beinlich UF, Baker W,Hinkle GH, Hung JC, Quinton T, Rice PA, Divgi C, Norenberg JP. A Performance Evaluation of Y-90 DoseCalibrator Measurements in Nuclear Pharmacies and Clinics in the United States. Appl. Rad. Isotopes., 66:252-260(2008).Hinkle G, Morosco R, Nahata MC. Extended stability of iobenguane under simulated clinical conditions.American Journal of Health-System Pharmacy, 65:142-4 (2008).Lai JP., Dalton J., Knoell DL. Phosphatase and Tensin Homolog Delected on Chromosome Ten (PTEN) as aMolecular Target in lung epithelial wound repair. Bri. J. Pharmacol., 152:1172-1184 (2007).Urbano RL., Baxley M., Blake K., Jones CA., Kelly HW., Knoell D., Lee T., Sherman B., Sutherland R., andWechsler M. Review of the NAEP 2007 Expert Panel Report (EPR-3) on Asthma Diagnosis and TreatmentGuideline. Journal of Managed Care Pharmacy, 14(1):41-49 (2008).Figg WD., Chau CH., Okita R., Preusch P., Tracy TS., McLeod H., Reed M., Pieper J., Knoell DL., et al.Pharm.D. pathways to Biomedical Research: The National Institutes of Health Special Conference on PharmacyResearch. 28 (7), 821-833 (2008).Crouser E, Exline M, Knoell DL and Wewers MD. Sepsis: links between pathogen sensing and organ damage.Curr. Pharm. Design. 14 (19): pp 1840-52 (2008).40

Besecker B., Bao S., Bohacova B., Papp A., Sadee W., Knoell D.L. The Zinc Transporter SLC39A8 is Critical inZinc-Mediated Cytoprotection. Am. J. Physiol. Lung Cell Mol. Physiol., 294: L1127 - L1136 (2008).Swaan P., Bahadduri P., Bensman T., Hall M., Knoell DL. Molecular Insight into Bacterial Peptide Recognitionand Immune Activation by the Human Peptide Transporter PEPT2. In Press 2008. Am. J. Respir. Cell Mol. Biol.,10.1165/rcmb.2008-0059OC (2008).Lacombe V.A., Viatchenko-Karpinski S., Terentyev D., Emani S., Sridhar A., Bonagura, J.D., Feldman D.S.,Gyorke S., and Carnes C.A. Mechanisms of Impaired Intracellular Calcium handling underlying DiastolicDysfunction In Diabetes. Am J Physiol Regul Integr Comp Physiol, 293:R1787-97 (2007).Dirksen WP, Lacombe V.A., Chi M, Kalyanasundaram A, Viatchenko-Karpinski S,Terentyev D, Zhou Z,Vedamoorthyrao S, Li N, Chiamvimonvat N, Carnes CA, Franzini-Armstrong C, Györke S, Periasamy M. Amutation in calsequestrin CSQD307H impairs SR calcium storage and release functions and causes polymorphicventricular tachycardia in mice. Cardiovascular Research, 75:69-78 (2007).Votion D.M., Navet R., Lacombe V.A., Sluse F., Essén-Gustavsson B., Hinchcliff KW, Rivero J.L.L., Serteyn D.,Valberg S.J. Muscle Energetics In Exercising Horses. Equine and Comparative Exercise Physiology Journal, 4:105-118 (2008).Lacombe VA and Andrews M. Electrodiagnostic in neuromuscular diseases. In Equine Neurology. Editors: SMReed and M. Furr. Blackwell Publishing Co, pp 127-148 (2007).Lacombe VA and Furr M. Seizures. In Equine Neurology. Editors: SM Reed and M.Furr. Blackwell Publishing Co.pp 77-93 (2007).Stojanovski S, Nahata MC. Implications of diphenhydramine single dose unintended ingestions in youngchildren. Pediatric Emergency Care, 23:465-468 (2007).Stojanovski S, Rasu R, Balkrishnan R, Nahata MC. Trends in medication prescribing for pediatric sleepdifficulties in US outpatient settings. SLEEP, 30:1013-7 (2007).Nahata MC, Beck D, Draugalis R et al. The academy’s agenda for improving the safety of medication use.American Journal of Pharmaceutical Education, 71:1-4 (2007).Phan H, Nahata MC. Clinical uses of dexmedtomidine in pediatric patients. Pediatric Drugs, 10:4-69 (2008).Nahata MC. Tips for writing and publishing an article. Annals of Pharmacotherapy, 42:273-7 (2008).Pai, V, Nahata MC. Drug dosing in pediatric patients. In: Clinical Pharmacokinetics, 4th edition. Murphy(editor), ASHP, 371-389 (2008).Pedersen CA, Schneider PJ, Scheckelhoff DJ. "ASHP National Survey of Pharmacy Practice in Hospital Settings:Prescribing and Transcribing – 2007." American Journal of Health-System Pharmacy, 65:827-843 (2008).Pruchnicki MC, Rodis JL, Beatty SJ, Clark C, McAuley JW, Mehta BH, Pedersen CA, Protus B, Bennett MS.Practice-based research network as a research training model for community/ambulatory pharmacy residents. J.Am. Pharm. Assoc., 48:191-202 (2008).Vanderbush RE, Anderson HG, Fant WK, Fujisaki BS, Malone PM, Price P, Pruchnicki MC, Sterling TL,Weatherman KD, Williams KG. Implementing pharmacy informatics in college curricula – the AACP Technologyin Pharmacy Education and Learning Special Interest Group. Am. J. Pharm. Ed., 71: Article 117 (2007).Tkacz VL, Metzger A, Pruchnicki MC. Tools and strategies to address health literacy in pharmacy settings. Am. J.Health Syst. Pharm., 65:974-81 (2008).Rodis J. Chronic hepatitis C virus infection: a review for pharmacists. J. Am. Pharm Assoc., 47(4):508-20; quiz508-20 (2007).41

Schneider PJ. Technology-related findings from ASHP’s surveys of pharmacy practice in hospitals and otherstudies. In: Effective Approaches to Standardization and Implementation of smart pump technology. HuntingdonValley, PA: Institute for Safe Medication Practices, 4-6 (2007).Schneider PJ, Ed. Preventing medication errors: The Institute of Medicine report. Am. J. Health-Syst Pharm.,64(Suppl 9) (2007).Schneider PJ. Opportunities for pharmacists. In: Schneider PJ, Ed. Preventing medication errors: The Instituteof Medicine report. Am. J. Health-Syst. Pharm., 64(Suppl 9):S10-6 (2007).Schneider PJ, JE Murphy, CA Pedersen. Impact of medication packaging on adherence and treatment outcomein older ambulatory patients. JAPhA, 48:58-63 (2008).Enrique Seoane, Stephen Schondelmeyer. Drug Patent Life and Generic Entry: Analysis of the New MolecularEntities Approved by the FDA between 1980 and 1999. Journal of Pharmaceutical Finance, Economics and Policy,16(4). In press (2008).Enrique Seoane, Rosa Rodriguez-Monguio. Drug Access in Guyana: The Need for Strengthening the PublicHealth Functions. International Journal of Health Planning and Management. Epub (2008).Jaclyn M. LeBlanc, Enrique Seoane, Trudy C. Arbo, Joseph F. Dasta. International Critical Care HospitalPharmacist Activities. Intensive Care Medicine, 34(3):538-42 (2008).Jaclyn M. LeBlanc, Enrique Seoane, Joseph F. Dasta. Survey of hospital pharmacist activities outside of theUnited States. American Journal of Health-System Pharmacy, 64:1748-55 (2007).Harpe, SE, Szeinbach, SL, Caswell, RJ, Corey, R, McAuley JW. Patient preference and the decision to medicatein overactive bladder, J. of Urology, 178-2532-2536 (2007).Valluri S, Seoane-Vazquez E, Rodriquez-Monguio R, Szeinbach SL. Drug utilization and cost in a Medicaidpopulation: a simulation study of community vs. mail order pharmacy, BMC-Health Services Research, 7:122(2007).Szeinbach SL, Jackson M. Here is the case for the urge in administrative claims database research aboutoveractive bladder. Journal of Managed Care Pharmacy, 14(3):309-311 (2008).42

NIH Grants Awarded FY2007NIH, Principal Investigator:Name Institute Project Title AwardChan, Kenneth K National Cancer Institute Preclinical pharmacological study $536,968of antitumor and other therapeutic agents.Chen, Ching-Shih National Cancer Institute Targeting Akt and Bcl-2 in prostate $279,963cancer prevention.Curley, Robert W Jr National Cancer Institute Analog studies of 4-HPR and its glucuronide. $282,094Dalton, James T Nat Inst Diabetes, Digestive, Pharmacology of nonsteriodal androgen $327,609& Kidney Diseasesreceptor ligands.Elton, Terry S National Heart, Lung, and Human angiotensin II receptor gene $262,500Blood Instituteregulation.Knoell, Daren L National Heart, Lung, and The cytoprotective role of zinc transporters $371,807Blood Institutein human lung epithelia.Kvaratskhelia, Mamuka Nat Inst of Allergy Structural studies of HIV-1 integration. $229,173& Infectious DiseasesKvaratskhelia, Mamuka Nat Inst of Allergy HIV-1 gag structure as a therapeutic target. $254,038& Infectious DiseasesLee, Robert J National Cancer Institute Targeted liposomal doxorubicin $571,446delivery to leukemia.Schmittgen, Thomas D National Cancer Institute Real-time PCR expression profiling $210,183of microRNA.Werbovetz, Karl A Nat Inst of Allergy Simple, selective antimitotic antiparasitic $298,763& Infectious Diseases agents.Wientjes, M Guillaume National Cancer Institute Enhanced chemosensitivity of $258,035pancreatic cancer.NIH via subprojects and subcontracts:Name Institute Project Title AwardDalton, James T National Institutes of Health Novel irreversible SARMs for $123,309prostate cancer.Other Federal Agencies, Associations, Foundations:Name Agency Project Title AwardChen, Ching-Shih Susan G Komen Breast Cancer Sensitizing ER-negative breast cancer $125,000Foundationcells to tamoxifen-induced apoptosisby a pdk-1 inhibitor.Dalton, James T Army Medical Research Tubulin-Destabilizing Bis-Indoles $449,085Acquisitionfor advanced prostate cancer.Hayton, William L National Science Foundation Modeling the salmonid hypothalamus- $350,086pituitary-gonad axis.Hoyt, Dale G Army Medical Research Effects of synthetic disintegrins on $106,000Acquisitionbreast cancer in mice.Hoyt, Kari R American Parkinson Disease Chronic biguanide exposure as a new $50,000Associationmouse model of Parkinson's disease.Lacombe, Veronique A American Heart Association Common mechanisms of diastolic $65,000dysfunction and arrhythmias in diabetes.Schmittgen, Thomas D Army Medical Res & Material Aptamer drug conjugates for prostate $79,365Commandcancer therapy.Werbovetz, Karl A Univ of North Carolina Development of new drugs to treat $83,293(Gates Foundation)Leishmaniasis and late stage human Africantrypanosomiasis.43

NIH Grants Awarded FY2008NIH, Principal Investigator:Name Institute Project Title AwardAu, Jessie L National Cancer Institute Chemoresistance in renal cell cancer. $261,855Au, Jessie L National Cancer Institute Telomeres, telomerase and chemotherapy: $312,217Bench to bedside.Carnes, Cynthia A National Heart, Lung, and Heart failure and atrial fibrillation $379,208Blood InstituteChan, Kenneth K National Cancer Institute Preclinical pharmacological study $601,163of antitumor and other therapeutic agents.Chen, Ching-Shih National Cancer Institute Targeting Akt and Bcl-2 in prostate... $279,963Dalton, James T Nat Inst Diabetes, Digestive, Pharmacology of nonsteriodal androgen $327,067& Kidney Diseasesreceptor ligands.Elton, Terry S National Heart, Lung, and Human angiotensin II receptor gene $254,888Blood Instituteregulation.Kinghorn, A Douglas National Cancer Institute Discovery of Anti-Cancer Agents of $1,365,636Diverse Natural Origin.Knoell, Daren L National Heart, Lung, and The cytoprotective role of zinc $375,000Blood Institutetransporters in human lung epitheliaKvaratskhelia, Mamuka Nat Inst of Allergy & HIV-1 integrase structure and function $98,798Infectious Diseasesas a therapeutic target.Kvaratskhelia, Mamuka Nat Inst of Allergy & Structural studies of HIV-1 integration. $396,484Infectious DiseasesLacombe, Veronique A Nat Center for Research Impaired myocardial glucose transport $253,800Resourcesduring diabetes: the novel role...Lee, Robert J National Cancer Institute Microfluidic synthesis of nanoparticles... $159,422Schmittgen, Thomas D National Cancer Institute Real-time PCR expression profiling of $209,172microRNA.Sun, Duxin National Cancer Institute An integrated system for tumor detection... $570,000Wientjes, M Guillaume National Cancer Institute Enhanced chemosensitivity of pancreatic $258,035cancer.NIH via subprojects and subcontracts:Name Institute Project Title AwardChen, Ching-Shih NIH via University of Chicago Development of Small-Molecule $150,000Autophagy-Inducing Agents Against...Lee, Robert J Lynntech, Inc Targeted gene therapy using synthetic... $20,000Other Federal Agencies, Associations, Foundations:Name Agency Project Title AwardBalkrishnan, Rajesh Wake Forest Univ Health Sci Center for dermatology research. $42,000Bellebaum, Katherine L Agency for Healthcare Res The Relationship between Nurses' Work $37,124& QualityHours, Fatigue, and Medication...Hayton, William L National Science Foundation Modeling the salmonid hypothalamus- $347,663pituitary-gonad axis.Lacombe, Veronique A American Heart Association Common mechanisms of diastolic... $65,000McAuley, James W Epilepsy Foundation of America Impact of AED Reduction on Economic, $3,000Clinical and Humanistic Outcomes in...Werbovetz, Karl A Univ of North Carolina Development of new drugs to treat $124,940(Gates Foundation)Leishmaniasis and late stage human...Werbovetz, Karl A World Health Organization Synthetic/medicinal chemistry... $102,28944

Alumni AffairsA lumni are proud of the high ranking of their alma mater and support the mission of the Collegewith their talents, time and resources. Many serve as preceptors in the College experiential programsand are dedicated to quality educational interaction with students. Alumni also serve on the alumniboard and committees, prospective student interviews, and as College recruiters.The OSU College of Pharmacy Alumni Society Awards Banquet and 25th Annual Meeting was heldon May 9, 2008 at the Blackwell Hotel and Conference Center on campus. The banquet was attendedby faculty, alumni, students and their guests. Another group of dedicated alumni were selected byProfessor Kristin Casper and the Alumni Relations Committee.Distinguished Alumni Award recipients must have a professional degree (BS, MS, PharmD) from theOSU College of Pharmacy, have made distinguished contributions in the fields of public health andpublic service, have performed outstanding activities in the interest ofthe College and its students, and have an outstanding record in theprofession of pharmacy.Lou MarcyDirector, Alumni AffairsDistinguished Alumni Awards:❖ Louis W. Marcy, RPh, Alumni Affairs Director, College ofPharmacy, The Ohio State University❖ Laura A. Shaw, RPh, Vice President of Pharmacy Acquisitions,Rite Aid Corporation, Appointed to Michigan Board of Pharmacy❖ Jerry Siegel, PharmD, FASHP, Senior Director of PharmaceuticalServices, Ohio State University Medical Center, Clinical AssociateProfessor and Assistant Dean, College of Pharmacy, The Ohio StateUniversityThe Jack L. Beal Postbaccalaureate Alumni Award is named in honor of the late Jack L. Beal, PhD,1952, Professor Emeritus of Medicinal Chemistry and Pharmacognosy at The Ohio State University.The recipient of the Jack Beal Award must have a postbaccalaureate degree (MS, PhD, or PharmD)from The Ohio State University College of Pharmacy and shall have contributed significantly toresearch and scholarships in the pharmaceutical sciences and/or contributed outstanding service to theprofessional practice of pharmacy.Jack L. Beal Postbaccalaureate Alumni Award Recipients:❖ Russel Allinson, MS, Therigy, LLC❖ Steven L. Bramer, PhD, Vice President, Angiotech Pharmaceuticals❖ Joseph F. Dasta, PharmD, Professor Emeritus, College of Pharmacy,The Ohio Sate University❖ Robert L. Stephens, Jr, PhD, Associate Professor, Department of Physiology,The Ohio Sate UniversityThe Josephine Sitterle Failer Alumni Award recipient is named in honor of Josephine Sitterle Failer,BS, 1939 (d. 1987), a long-time College benefactor who contributed service to the College for nearlyfive decades. The award recognizes an alumnus who has received a professional degree from the Collegeof Pharmacy within the past ten years and has made outstanding contributions to community orprofessional service.Josephine Sitterle Failer Award Recipient:❖ Michael B. Doherty, PharmD, Assistant Professor of Clinical Pharmacy Practice, Directorof Experiential Training, College of Pharmacy, University of CincinnatiDon Bennett, our new Presidentof the Alumni Society, describeshis profession in a very simpleway. “At the heart of it’, he says,“we simply take care of people”.But the profession is varied, thereare many different ways toaccomplish this; ambulatorysettings, long-term care, diseasemanagement, research, etc. Hewould like to see his colleaguesconcentrate more on what ties usall together rather than ourdifferences.He sees this more than ever inthe activities of professionalorganizations like the AlumniSociety. Here is our chance tonetwork, pick up importantinformation from others andcollaborate to bring improvementsto our profession, and in the end,to our patients. The Society isfocussed now on strategicplanning that will dove-tail withthe OSU Alumni Society strategicplan. The presence of OSU alumniin the US, and internationally, isastounding. We can stayconnected with students asmentors and preceptors andtogether contribute our time andskills to promote our profession inthe health care arena.Don’s wife, Amy, is apharmacist and is the AssistantExecutive Director for the OhioPharmacist Association.45

THE OHIO STATE UNIVERSITY COLLEGE of PHARMACYALUMNI SOCIETY GOVERNING BOARD ROSTEROfficer Name Degree, Year Location Pharmacy Practice SitePresident Donald L. Bennett, B.S. '70 Westerville, OH HospitalPresident-Elect Larry C. Schieber, B.S. '81 Circleville, OH CommunityVice President Kathy Nameth B.S. '80Secretary Kimberly L. McDevitt B.S. '81 Columbus, OH CommunityTreasurer Col. John J. Coughlin B.S. '56 Westerville, OH Community (retired)ImmediatePast President Linda F. Bendinelli, B.S. '80 Columbus, OH HospitalAlumni Thomas P. Sherrin B.S. '65, M.S. '67 Powell, OH Health Care OrgRepresentativeto the OSUAAAlumni AdvisoryBoardRepresentative Name Degree, Year Location Pharmacy Practice SiteDistrict 1(2007-2011) Dale A. Bertke B.S. '85 Minster, OH Long Term CareDistrict 2(2005-2009) Cecilia "Ceil" Canestraro B.S. '81 Urbana, OH HospitalDistrict 3(2007-2011) Michael Scott Ferriell B.S. '76 Brookville, OH HospitalDistrict 4(2005-2009) Mark P. Mershon B.S. '89 Cincinnati, OH CommunityDistrict 5(2003-2007) Creg F. Stockwell B.S. '77 Washington C.H., OH HospitalDistrict 6(2005-2009) Lorrie L. Burns Pharm.D. '03 Blacklick, Ohio HospitalShirlyn Chaffin B.S. '59 Westerville, OH CommunityAmira E. Del Tosto B.S. '93 Columbus, OH CommunityNiesha Griffith M.S. '96 Columbus, OH HospitalRobert S. Hayman B.S. '64 Grove City, OH CommunityMary Beth Kanatas B.S. '80 Columbus, OH CommunityGregory D. Kuck Pharm.D., '00 Columbus, OH Federal PharmacyDavid H. "Doc" Lamberjack B.S. '93 Dublin, OH CommunityJohn A. Lince B.S. '64 Columbus, OH CommunityDale C. Lucas B.S. ’67 Gahanna, OH CommunityJanet Senek Robertson B.S. '84 Columbus, OH Nuclear PharmacyBonnie Croce Spiers B.S. '71 Westerville, OH IndustryMarilyn Keish Wollett B.S. '65 Columbus, OH Mail Order RxDistrict 7(2007-2011) Susan Brown B.S. '76 Morral, OH CommunityDistrict 8(2005-2009) Christopher L. Hirt B.S. '95 Fremont, OH HospitalDistrict 9(2007-2011) Dr. Brian Frank George B.S. '96, Pharm.D.'98 Lexington, OH HospitalDistrict 10(2005-2009) Eric M. Hals B.S. '89 Pataskala, OH CommunityBenjamin A. “Andy” Black B.S. '94 Pickerington, OH ClinicalDistrict 11(2007-2011) Kenneth Lee Warman B.S. '78 Portsmouth, OH CommunityDistrict 12(2005-2009) Kenneth D. Crist B.S. '80, Pharm.D. '83 Zanesville, OH Res/Clinical PracticeDistrict 13(2007-2011) Jerry S. Marlowe B.S. '61 Dover, OH Long Term Care/CompoundingDistrict 14(2005-2009) John A. Nees B.S. '51 Louisville, OH CommunityDistrict 15(2007-2011) Kathleen D. Donley B.S. '77, MBA Hudson, OH Health SystemDistrict 16(2005-2009) Virginia Lynn Beaty B.S. '96 North Olmsted, OH CommunityInga Becker-Gutarts B.S. '98 Solon, OH CommunityScott G. Jamieson B.S. '82 Lexington, OH HospitalJeffrey M. Ketz, PharmD ’97, BS ’88 Cleveland, OH HospitalDistrict 17(2007-2011) Gary Lee Kabetso, Jr. B.S. '94 Canfield, OH Health SystemDistrict 18(2005-2009) Brent J. Swipas B.S. '90 Warren, OH Community46

Out-of-State Name Degree, Year Location Pharmacy Practice SiteRepresentatives(2003-2007) Robert P. Henderson B.S. '81, Birmingham, AL EducationPharm.D., UT '03Andrew J. Irons B.S. '98, Leola, PA Clinical CommunityPharm.D. '00(2005-2009) Douglas A. Miller B.S. '72 Plymouth, MI HospitalLaura Matchett Shaw B.S. ‘87 Waterford, MI Chain ExecutiveKaren Balcerzak B.S. '80 Red Bank, NJ Oncology Sales Rep.Board Appointees(2004-2008) A. Joel Arnold B.S. ’58 Cleveland, OH Chain management(Retired)(2005-2009) Phyllis Grauer B.S. '77 Plain City, OH Palliative Care(2005-2009) Robert J. Dupont Sr. B.S. '62 Columbus, OH Community(2005-2009) Terry Light Fraker B.S. '69 Perrysburg, OH LT Care/ Infusion(2005-2009) Paul E. Herring B.S. '68 Reynoldsburg, OH Consultant Pharmacy(2005-2007) Jeffrey R. Legg B.S. '91, M.S. '92 Westerville, OH Health Care Org(2004-2008) J David Luckhaupt B.S. '50 Powell, OH Retired HS Admin(2007-2011) Frank Sainato B.S. '58 Westerville, OH Chain management(2005-2009) Military Col. Jerry F. Pierson BS '80, Ph.D. '97 Frederick, MD US Army/Research(2003-2007) James W. Staker B.S. '56 Portsmouth, OH Community(2005-2009) Sara New St. Angelo B.S. '76 Indianapolis, IN HospitalLifetime Member Name Degree, Yearin Memoriam Jack L. Beal Ph.D.'52Robert W. Jones B.S. '48Josephine S. Failer B.S. '39Richard I. Wells B.S. '56Lifetime Member Name Degree, Year Location Pharmacy Practice SiteCharles W. “Bill” Ague B.S. '50 N.E. Ohio RetiredLt. Col. Ralph V. Foster B.S. '56 Columbus, OH Industry (ret.)Daniel B. Waitzman B.S. '43 Columbus, OH Community (ret.)Alumni Affairs Lou Marcy B.S. '65 Columbus, OH Clinical PartnersDirector47

Outreach and EngagementThis has been an exciting year for Outreach and Engagementactivities of the students and faculty at OSU College of Pharmacy.Partnership expansion and innovation have been hallmarks of the year.The leadership provided by faculty and student leaders has beenexceptional. In addition to the continued excellent outreach andengagement efforts by students (immunizations, health screenings,diabetes and asthma education, to name a few), there has beenexpansion of existing outreach programs with many new initiatives.“Pills, Potions, and Poisons”High School Students DiscoverPharmacologyGerald CableDirector, Outreach andEngagementThis summer at the College fourteen high school studentsparticipated in a science-oriented, first of its kind, summer studies course for local highschool students, aimed at sparking an academic interest in science and future careers in thepharmaceutical sciences. “Pills, Potions, and Poisons” gave students an overview of the fieldof pharmacology and its relationship to health, disease, and society, under the closedirection of Dr. Nicole Kwiek, Assistant Professor in Medicinal Chemistry andPharmacolognosy and Assistant Director for Educational Outreach.Students explored pharmacology through lab experiments, debate, team projects, andfield trips around OSU. Guided by questions such as: How do drugs work? What are thedifferences (or similarities) between “good drugs” that cure disease and “bad drugs” that areused recreationally? How do drugs treat pain, cancer, or infectious diseases? Why do onlysome drugs work in thebrain? How do we discovernew drugs?Dr. Kwiek assessed theprogram with pre- and postcoursesurveys, showing thatstudents made significantlearning gains in basicbiology and chemistry.Furthermore, afterparticipating in the program,students were more likely toindicate heightened interestin biomedical careers.What the numbers do nottell us can only be gleanedfrom the smiles on their facesin this group photo.48

OSU/OU Educational CollaborationThe College of Pharmacy at the Ohio State University and Department ofChemistry and Biochemistry at Ohio University have a long history of cooperationrelated to admissions information in regards to our graduate-professional andgraduate-research programs in pharmacy. This inter-institutional collaboration wasenhanced through a Course Development Grant from OSU’s Office of ContinuingEducation for a teleconferenced “Introduction to Pharmacy” course offered SpringQuarter 2008. The course was designed to expose students to the history,development, current scope of practice, educational requirements, ethicalfoundations, regulation, contemporary issues and career opportunities in theprofession of pharmacy. An innovative “Introduction to Pharmacy” web site wasdeveloped for use in the course including digital “Pharmacists’ Stories” to helpstudents learn more about professional practice. Twenty-eight students at OU’sAthens campus engaged in this course along with several OSU students. Positiveoutcomes are leading to discussions of future partnerships and outreachcollaborations.Pharmacy StudentsVisit the UnitedKingdomThis summer twenty-seven students, facultyand staff, from the College journeyed “acrossthe pond” for a visit to London, England toexplore the practice of pharmacy in the UK.The BSPS and PharmD students learnedeverything from English history to proper teaetiquette and engaged in student-ledpresentations about various facets of pharmacyin the UK. Topics ranged from the Englishsocialized medicine system to education and licensureof pharmacists in the UK.Our students came away with a much betterunderstanding of socialized medicine. They observedthat in Great Britain, a pharmacist’s practice scope ismuch broader. Aside from the ability to prescribe, UKpharmacists place an emphasis on their clinical roles,regardless of the practice setting. Recently, the Britishgovernment outlined plans to extend healthcareservices available through community pharmacies. Theclass agreed that this visit to England opened theireyes to the healthcare systems in other countries andthat, as new pharmacists, they might become involvedin revolutionizing the healthcare system in the US.49

The Generation Rx InitiativeNo matter what your age, you belong to “Generation Rx.” We all takemedications at unprecedented rates, and often expect “quick fixes” throughpharmaceuticals as opposed to behavioral changes to solve our problems – we livein a drug-taking culture. The pharmaceuticalization of our society has providedmany benefits. We are living longer, and many previously fatal diseases havebecome chronic conditions. But our use of prescription and nonprescriptionmedications presents problems as well, in the form of adverse drug events and theincreasing abuse of these substances.The Generation Rx Initiative is a learning community established at theCollege of Pharmacy in 2007. Students, faculty and staff are learning more aboutmedication safety issues in our society under the leadership of PharmacyProfessoprs Jerry Cable, Ken Hale, Nocole Kwiek and Lane Wallace. The group isparticularly concerned about the pervasive abuse of prescription andnonprescription medications, and is developing resources and programs to combatthis rising trend. The initiative developed a website to provide links and usefulinformation for the public.The Generation Rx Initiative focuses on educational outreach to students at alllevels (“K through College”) as well as in our communities. Many of these effortsare developed and presented by our undergraduate or professional students. A fewexamples of programming initiated by Generation Rx Initiative:❖ “Medication Safety Patrol” – a collection ofresources/programs for elementary students andteachers❖ OTC programming for middle schools based on theFDA’s “Medications in My Home” program❖ A high-school based program currently beingdeveloped in collaboration with a student at NewAlbany High SchoolJerry CableKen Hale❖ “Generation Rx and the Abuse of Medications in aDrug-Taking Society” – a discussion-basedworkshop for students at Ohio State being offeredthrough the University’s First-Year Success Series❖ “Pharming to Get By?: The Truth About AbusingPrescription Stimulants” – a skit & discussion-basedworkshop for students at Ohio State being offeredthrough the University’s First-Year Success Series❖ The development of a partnership with Columbus’Center of Science and Industry (COSI) to provideeducational outreach relating to medications (e.g.,“Electronic Experts” and parent educationalprograms)Nicole KwiekLane Wallace50

Global Pharmacy InitiativesThe College of Pharmacy is actively engaged in faculty exchanges, studentexchanges, and international collaborations with the schools/colleges of pharmacyaround the world. Official agreements on research, teaching and practice-relatedcollaborations have been initiated with five schools/colleges of pharmacy in Taiwan.Ohio State faculty participated in scientific and practice symposia in Taiwan, metwith faculty and students, and toured research and practice facilities. Facultymembers and pharmacy students from National Taiwan University (NTU) andChina Medical University (CMU) visited Ohio State in 2007-08 for research andpharmacy practice training. Two M.S. pharmacy students from NTU visited OSU insummer 2008 for experiences in hospital and community pharmacy settings. Also,several faculty and pharmacy students from CMU were involved in research studies insummer 2007 and 2008. Subsequent discussions are focusing on new distanceeducational opportunities for Taiwan pharmacy students and faculty in clinicalpharmacy.Members in the US-Thailand Consortium of Schools/Colleges of Pharmacy,formed in 1993, we focus on advanced degree opportunities for Thai students. Thisagreement was extended in July 2008 by the US and Thailandschools/colleges for another 15 years and expanded to includeadvanced training in clinical pharmacy areas as well as graduateeducation in the pharmaceutical sciences. Additionalinternational pharmacy exchanges include the student trip toLondon in June 2008, P-4 pharmacy student clerkships at St.Thomas Hospital (London), and pharmacology faculty andstudent exchanges with the University Central of VenezuelaFaculty of Pharmacy. Finally, the College is an activeparticipant in the newly established Fogarty Center for GlobalHealth at The Ohio State University Health Sciences.Ya-Ting Kuan (CMU), Wan-TsengHsu (NTU), Yea Harn Yang (NTU),Chen Fang Weng (CMU)Delegation from China Medical University, Taiwan, visits Ohio State College of Pharmacy51

DevelopmentDr. Betty-ann Hoener (74 PhD),emeritus faculty University ofCalifornia San Francisco inBiopharmaceutical Sciences,endowed a fund to supportstudents in the College ofPharmacy graduate program. Aspriority for Ohio State, studentsupport is paramount to theColleges ability to recruit thebest and brightest students.Dr. Hoener provided this giftbecause, "I wanted to be able tosay thank you to the College forgiving me the skills I needed todo the work I love to do. Iparticularly wanted to give abonus to a graduate student at atime when I know I would havemost appreciated it."Her named fund, the Betty-annHoener Graduate Endowed Fundin Pharmaceutics, providesfunding for an outstanding seniorgraduate student inPharmaceutics. The Collegerecognized Dr. Hoener at theCollege Research Day, May 19,2008.The first graduate to receivethe Hoener Graduate award,Chien-Ming Li, received both hisBS and MS in Chemistry fromNational Cheng Kung Universityin Taiwan. His research focus ison In Vitro Pharmacology andMetabolism of 2-Arylthiazolidine-4-carboxylic acid Amides.It was an exciting year in development forthe College of Pharmacy. Two endowmentsthat support students reached full endowedstatus this year. Both funds provide muchneeded support for the graduate program.The Timothy D. Moore Award recognizesthe accomplishments of a student in thehealth systems pharmacy program and theBetty-ann Hoener graduate award rewards astudent in pharmaceutics. The College alsoreceived a generous gift from Eli Lilly for afellowship supported on an annual basis forthree years. A special gift from alumnus Dr.Robert Ruffalo and wife, Stephany, namedthe newly renovated lecture hall, Room103,the Ruffalo Lecture Hall.Fiscal year 2008, the College ofPharmacy raised $1,808,470 inprivate support in the form ofcash, securities, plannedgifts, and gifts-in-kindand $392,496 in nongovernmentgrants fora total of$2,200,966. Inprivate supportalone, the Collegerealized a 105%increase over last year.Moreover, the Collegemore than doubled thenumber of donors whocontributed to enhancingeducation and advancing theprofession of pharmacy.Shannon WeiherDirector of DevelopmentRuffalo Room Dedication. LectureHall 103 in Parks Hall received acomplete renovation this summer.This project was made possiblethanks to the generous support ofRobert ('73 BS, '76 PhD) andStephany Ruffolo of Spring City, PA.The College dedicated the RuffoloLecture Hall on October 10, 2008.Said Dr. Ruffolo (left), "I spent nearly10 years in the College of Pharmacy,both as an undergraduate andgraduate student in Pharmacology.The success that I haveexperienced is founded in theeducation I obtained from OSU. Sowhen I had the opportunity andthe financial means to give back, Idecided to give to the institutionthat played such an important rolein my career. The decision torenovate lecture room 103 wasbased on the fact that I had, as astudent, spent so very many hoursin that room at a time when theroom and its facilities were brandnew. I wanted to provide that samebenefit to today’s students.Stephany and I are thrilled to beable to make this happen"The Ruffolo Lecture Hall will beequipped to handle videoconferencing;lecture capturetechnology and emerging wirelesstechnology for student participationin class discussions. We are allexcited for the new teachingenvironment made possible by theRuffolo gift.52

College of Pharmacy Honor Roll for Fiscal Year 2008We are very grateful to the many generous benefactors who continued to support all areas of The OhioState University College of Pharmacy during the fiscal year 2008 (July 1, 2007 through June 30, 2008).Although every effort was made to insure the following list is complete and accurate, errors may bepresent. We would appreciate a note from you if you find an error.$5000 and aboveAmerican Foundation forPharmaceutical EducationAnonymousAvatar FoundationFloyd G and Betsy P BenderHoward N andKathleen G BockbraderPamela L BonerCardinal Health FoundationChih-Ming J and Virginia C ChenCommunity Fdns Inc - Cyril FundMichael F and Sharon M CurtinEnlyton LtdGiant Eagle IncBetty-ann HoenerGerald J and Jody HudecDavid K JonesKroger CompanyLawrence D andMaryann Z KennedyLilly Grant Office of Eli Lilly& CompanyMedco Health Solutions Inc& Medco Health AffiliatesNature's Sunshine Products IncNuclear Pharmacy CertificateProgramOles & Associates LLC CPA'sOSU College of PharmacyAlumni SocietyDavid A and Sandra L SmeenkJames W and Sally A StakerAlfred E and Angela P StaubusThe Sherrington GroupJeannette T ThouveninAllan K and Linda VrableWalgreen CorporationMarilyn K WollettJinn and Diana Wu$1,000 - $4999Academy of Pharmacyof Central Ohio ScholarshipACCP Research InstituteAmerican Association of Collegesof PharmacyAmerican Pharmacists AssociationAmerican Pharmacists AssociationFoundationAmgen IncRobert L and Roberta M ArmstrongDonald L and Amy BennettJon W and Marialice S BennettStephen W BirdwellRafik BisharaRobert W andSusan Y BrueggemeierCancer Association of Darke CountyJohn M and Nancy L CassadyJoseph A and Mary S CusmaJames P and Anita P Di CelloBruce L DowneyShaaban F and Leticia J El NaggarJohn E FedynaFoundation for Managed CarePharmacyMaria C FowlerKenneth M and Karen N HaleKim D and Judy L HawksworthDonald E and Saundra D HillJohnson & JohnsonAlan S and Sandra T KatzAmol S and Vaishali KetkarBarry E and Ann M KleinDonald O and Nancy D LamportBrandon S and Kelly D LutzMichael A and Livia L ManbeckLouis W and Carol J MarcyJerry S and Mary MarloweGlen M and Donna C MelickCheryl L MooreJennifer MyerbergMylan Pharmaceuticals IncNACDS FoundationMilap C and Suchitra K NahataMichael A NamethRandall W and Kathleen M NamethNeoprobe CorporationMarcia I NusgartJames A and Patricia A OdomOhio Northern UniversityChris PaapJames E PaolettiMichael J PcolinskiTiffany Moore PeoplesPharmacists Mutual InsuranceCompanyNicholas S and Erika P RagajiGreg L and Patricia A ReamGeorge D and Betty W RichardsThomas J and Madonna M RimeleShirley C RobertsonLarry C and Kim M SchieberJerry SiegelMark A SirgoMark D and Stephanie J SzewczykThe J M Long FoundationThe Kroger Company -ColumbusUniversity of CincinnatiFoundationUptown Pharmacy LLC RetailManagement Products LTD LLPWal-Mart Stores IncLisa B WebsterKarol S WellsThomas E WhistonChristopher G and Suzanne M WidingScott E and Teresa K WilcoxPaul L and Mary N WitkowskiJohn F Wolfe and Ann I WolfeWyethJan H and Antoinette S Zimmerman$1 - $999Abbott Laboratories FundStephen P and Kathy W AbfallAllen E AchbachSteven E AckermanAdeboye AdejareCraig S AdieBarbara Jo AgueCharles W and Elma H AgueJoseph M and Peggy A AlbrechtJames L and Koula P AlexStephen T and Joan E AlguireRussel R AllinsonAlpha Medica IncAustin AltenburgAllrepsAmgen FoundationWilliam J and Nancy B AnderiesNinna W AndersonJerry AndryJack W AngermanPaul W and Martha B AnthonyHenry T ArmbrusterMarjorie M ArnoldJohn H ArtinoDouglas A AuerbachRoger P AustinAlbert T AwadDavid S and Jennifer L AzzolinaTimothy A BaileyWilliam T BainbridgeErica L BakerMichael L BakerThomas E and E J BakerCathy Balshone-Becze53

Robert J and Melanie A BangertBank of America Foundation &Charitable FoundationGladys H BannanKathleen G BarileJoel A and Diane P BaringerEric J and Lori C BarnhouseDarlene L BaronBarr Pharmaceuticals IncEleanor BarstowNicole T BartlettJohn F and Peggy R BaylinAlbert S and Katherine K BaumanStuart J BeattyKatherine L BellebaumMichael G and Patricia T BendinelliDoris W BennettRosemary R BerardiRichard I and Carol S BernardoCarolyn D BerryKirk F BetteridgeStephanie BieloskiBenjamin A BlackBrian C BlakemoreBenjamin A BlackfordJames M and Susan W BlackfordJames E BleadingheiserNicholas D and Melinda T BlosserAllison K BlozyJohn L and Barbara G BoggsJeffrey P BonnerHugh E and Catherine B BonnorontBrian Borders and Cherie B BordersJoseph L BorowitzKathryn A BowdenStasia V BowlingGary D and Sandra G BowmanMark E and Kristina S BoyeGarry D and Ellen D BoydJames E BradenNeil A and Christina W BragueBradley K andMichele Balint BrammerRoger D BraunEdward A BraytenbahJoanne C BricknerEric E BrightBristol-Myers Squibb Fdn -Matching Gift ProgramKathleen I BrooksWilliam R BrownThomas F and Susie S BrownThomas E Bruderly andValerie E TaylorRinaldo A BrusadinE C BuchananMary A BuckinghamMichael BuckleyStephen J BueningRichard and Elizabeth G BulgrinRobert J and Deborah P BurgerThomas J and Anne L BurnsAeron P and Jennifer J BurnsJohn G and Gunta E BurtJennifer L BurchettGerald A and Patricia G BurchHarold B and Beverly K BushmanRobert W and Judith D ButlerGerald L and Judith S CableJohn C and Cecilia T CanestraroThomas A and Carol CammDiane M CappellettyDennis L CareyCynthia A CarnesMark K and Lisa A CarrollSteve D and Susan B CarrBrian C CarsonCindy G CashPatrick J and Jennifer O CavanaghCedarville Pharmacy LLCCephalon Matching GiftsShirlyn K ChaffinAppavu and Thilagavathi SChandrasekaranRobert L ChapmanChing-Shih ChenJoyce CheungDonald H ChmielewskiJennifer T ClarkRichard E and Patricia B ClappAnn T ClarkJohn B ClarkJoseph C and Paula D ClarkSherry D ClaytonRichard R and Heidi K ClineNicole D CochranBradley A CollinsThomas J and Anne D ComstockCarolyn L ConnorJohn C and Miranda N CookChasity M CooperJay R and Barbara A CrabtreeLouis R and Kathryn P CraddockRichard T CranstonOtis L and Lois B CrawfordMargaret CremonaKenneth D and Martha K CristC M and Coleen K CrostonMark D and Angela G CroweTed M CrumStephen V and Gayle T CrumeCarol B CurryYong Cui and Yongmei ZhouElaine H CutlerKevin N DaleyJames V and Laura E DamiconeAlice DanielsBrenda S DavisHillary C DavisJames L DayRichard J and Leanna B De NealeLouis M and Rosanna L De SantisErin DelffsNancy R De WeeseLeonard M DembskiValerie A D’EramoHeather DetersSara M DeyoEdward A DiMicheleMary E DimuzioGuy A DiPasquaMark S and Jane M DominikJean C DrexlerMark W DorianThomas W and Linda DowlingJulie L DragojevicMichael J and Theresa K DrexlerJoseph B and Barbara T D’SilvaRobert R DuffyCarmela V DuvaDaniel J and Mary Ann R DzurecEdwin A and Linda G EarhartThomas L EaslySuzanne R EastmanFrederick M EckelRobert H and Dorothy A EhlersLester G and Eleanor EinhornBarbara S EisensteinEli Lilly & Co FoundationRobert J ElliottAugust L and Crescentia L ElsenerJason C and Angela ElversTron A and Ruth E EmptageLaura D EnlowStephanie L EnzTerrilyn J EstellJune EvansExxon Mobil Foundation54

Jay M and Susan A EzzoneJudith Z FinnWilliam and Jeannie FaganBeverly A FairBetty L FarwickBarbara N FavreauLee A FederanichMyron FeinbergStephen J FerenchaDennis R and Grace L FellerEmil J FerraraFidelity Char Gift Fund -Witcher-Bush Family FundJoseph L and Maureen M FinkWilliam B and Karen F FisherA L and Naomi G FisherSuzanne S FitzpatrickHarold E FletcherRoberta FletcherWilliam J FlynnFMC Foundation MatchingGift ProgramStephen W and Sandra L FogtHarry H FongAngela T ForemanRyan A ForreyJohn W and Ann B FowbleRonald D FowlerKristine E FrankRobert E and Debra L FranzAlan F FriedmanMichael A and Nikki M FosterTamara M FoxEric FungRocco L and Sylvia Z FumiRenae R GaerkeElaine F GalantiMichael C GanioXiang Gao and Anh-Quynh TranPatrick M and Kim G GarmanChris A and Angela M GasserE K and Betty S GavinM S GavinLinda L GaydosMike and Katie GecewichCharles M and Ava R GegenheimerGeneral Guiness BandSteven G and Anne F GentryRobert E GeorgeJohn J GermaineJoel A and Terri D GhitmanMark E GiangardellaW D and Brenda P GibsonGordon V GiffinMartin R and Michelle A GiannamoreFrederick W and Joanne W GiesslerJeffery D and Amy C GivensGlaxoSmithKline FoundationSusan H GlazerGlobal Impact -TellabsGiving ProgramOumou K GnangMerna B GoettCalvin R Jr and Amanda J GoffTad A and Kerry H GomezAndrew D GonsMildred D GordonSuzanne E GrabanDonna J GroveDwain E GracyMichael D and Amy L GrahamBarbara E GrajzlPhilip P GramlichDennis W and Sharlyn A GrauerPhilip D GresselYale and Beverly GresselNiesha L GriffithEric W and Erin C GriffinRichard A and Terri L Marcus-GroverSteven E GubaPaul G and Sandra B GundlerGene L GunselmanSamir M and Elora GuptaH & R Block FoundationDaniel P and Amy S HaasSherry C HaberkernCarmen M HadleyMark A and Michelle HadleyEric M HalsThomas C HallEman H HammadMichael H HaneyJack B HannaPeggy E HannaRonald W HanningCharles J and Rachel S HarchaJames H HarrisEllen M HarrisonRussell W HarchaMarc W HarroldPeter J HartGary B and Patsy A HasemeierZaffar S HashmiLisa A HattenPhyllis A HavenerRamona M HawkinsTerry G HawkinsDonald D and Bernadine MHawksworthRobert S HaymanSheryl J HaysWilliam L HaytonJames V HeckmanBarbara S HeglerJacob H HendershotDaniel A and Wendy M HerbJohn C and Nicole T HerbertPaul E and Jo Ann HerringRobert G and Donna K HerrinBradford R and Erinne C HessFred D and Karen T HensleySidney R and Karen B HickmanThomas F and Evelyn HippleW D and Tamara O HippChristopher L and Denice M HirtPeter and Mrs Deanna R HirschAmy W HochMark H and Tina S HoewelerMichael H and Jodi M HoffmanJ T and Mary Kay F HoffmannPaul S HoffmannTimothy R HoffmanWilliam H and Donna N HohmanRobin V HoldermanMichael J Holley and Ina F HolleyAlvin J HomanAllen T HopperKrista R HopperLouis J HorvathDonald E and Karen K HostlerJames R HostlerDavid E and Susan C HowsonHarold E HuberPamela H HughesRobert C and Michelle M HughesD S HulkaMichael D and Kris HurdFu-Lian HsuMargaret A HuwerIBM International FoundationBrian L IhlenfeldJoel K ItoKristin Y IzenstarkAdam C and Sheila MThomas-JacksonLaura L JacksonMarie N JacquesHoward E and Ralph G JakwerthRobert M and Donna B James55

Scott G and Susan C JamiesonStephen W JanningJames R JansenYun Chi and Nancy M JaoEdward F Jirik JrJohnson & Johnson -MatchingGifts ProgMolly R JohnsonJohn J and Julie A JohnsonR M JohnsonShawn E and Michelle L JohnsonCraig T Johnston SrEileen B JohnstonRichard P Jones IIJack Lince PhotographyRebecca H JonesTrisha A JordanJohn S and Heather C JudinConnie T JungKenneth G and Susan L JozefczykBarbara B KlinkerPeter F KadorTiffany E KaiserDavid J KalisFrank W Kapronica JrBrad J and Patricia A Joynt-KarnsRachetta K KaseffJohn D and Karen S KaskewskyDalia Kavaliunas-BitenasMartha M KayJoanne S KaysRobert T KelleyPatrick R and Theresa C KellyCarol L KernJacqueline Z KesslerJeffrey M and Maureen C KetzKnot Fibb'nRobert W KidstonGrace M KilbaneJames L KingKing Dodson ArmstrongFinancial IncStephen J and Lisa Orr-KingeryMichelle M KingsburyDuane M and Marilyn H KirkingJoseph M and Karol A KirkLaura R KleinThomas J KlostermanKara S KniskaDaren L and Karen R KnoellThomas A KocarekPhilip R KochMarc W and Zieva D KonvisserTimothy E KostyBeth B KrauseGerald L and Elizabeth A Pressler-KremerVirginia B KrinnMelvin W KrootGail D KrugRobert J KuhnWilliam J and Carolyn W KuehnleAmit S KulkarniDavid A KvanczGregory A LaineJanet L LallathinJohn R Lange IIIKimberly C LarkinsBilly L and Susan E LattaClaudia H LauerTerry L LaurilaJames and Sue J LawlerRonald E LayDonald R LeachKaren D LeaverWilliam K and Nancy L LecainFred S LeftonJeff and Julie F LeggGary D LeggettJack LemanowiczMary Ann S LemkeS F LemonPaul E and Alice I LenkerEdward J and Alice C LeoneAllen J LetsomeKarl F LeupoldJames P and Barbara D LeydaRoger H and Susan A L'HommedieuJ L and Beverly C LichtinJohn A LinceEleanor G LieptzStephen J LinderScott LindsayKathleen S LippPaul S Liu and Barbara H LiuThe Susan & Leonard LodishCharitable FoundationSusan F LodishJames J LoganVictor N and Mary R LombardiVictor/Mary LombardiRevocable TrustJack R LoweLowell R LowaryMatthias C LuWilliam C and Charlotte K LubawyJune A LuddenNicholas A LungociuMichelle A MaguireWilliam* and Georgiana MangelsLaura L ManzeyMark A and Pamela B ManfrescaDaniel S and Jacqueline A MarowitzSteven G MarshThomas M and Claire J MarshallLawrence L and Arlene S MartinNouri Y MaryRichard and Mary L MasonDonald M and Kimberley W MassieKayoshi MasuokaJean M MathewsCharles A and Alice Jean B MatuszakVincent F and Laurie S MauroBilly W Maxwell JrMichael R and Barbara L MayerJon R MayFrank J MazzuccoMBR PharmacyPhillip J McAteerKim H McBethJesse E and Denise E McCalebRobert H McClanahanRonald J McCulleyTanya R McDayKimberly L McDevittJulie A McGloneKatie McGuirePatrick L McKercherFrank M McLainDavid J and Laura K McLeanCarmen M McKinneyRobert J McLoughlinKristine J McQueenMichael J and Cathy McQuoneJohn A and Kerri S MeansMed Central Health SystemMedical Arts PharmacyMedco Health SolutionsCharitable Match FundMelissa D MeekinsDavid J and Catherine L MeierPatrick E and Sally A MelragonWalter A Mendyka JrMerck Partnership for GivingMatching Gift ProgramDavid M and Jody R MeredithGregory R and Dr Debra S MerrillCarol H MeyerKaren E Miley56

Janet G MillerLaura J MillerNatosha Miller-EskanderDavid C and Julie S MoellerBarry A and Ramona R MoenterMarcia A Mohrfield-FerryRussell S and Ann K MolinarMomentum Capital CorporationStacy MoranHouston R MorganMichelle D MorrisAnn N MotticeRobert H and Lisbeth B MoyerJames W and Beverly B MunsonCynthia A MurnyackChristine C MurphyRalph L MusgraveMylan Laboratories IncAlvin & Louise Myerberg FamilyFoundation IncNat'l Heritage Fdn Char Trust-Leyda Family FoundationStephen S Navran Jr andMary F DemellierTodd W Nesbit andSuzanne A NesbitStephen E NesterDeborah H NewmanBetty S NicholCraig B NielsenDavid A NikulaTimothy L NisleyJoseph T NofelNovo Rx Holding Company IncCathy M NydickWilliam G OakleySusan D O'BrienThomas J and Jill G O'BrienThomas O OesterlingAdam G OgdenOhio Pharmacists AssociationOhio Pharmacists FoundationMichael A and Deanna H OlexiaJeanette P O'NealEdward M O'MaraJose A and Nicole C OrozcoJohn E PabstWilla L PantojaKeith A and Corlis M PappaCecelia S PariseEllis H and Kimberly B ParishDavid E Christine M ParkerRichard H Parrish IIPopat N and Betty B PatilCharles T and Pamela H PattonMichael T and Jenai S PaulRobert C and Diana PaxtonCraig A PedersenAlice J PenroseTracy R PenroseTodd O and Allyson A PerryLawrence J and Jean S PeskoBrian N PetersRobert J PetrikCarl T and Patty J PetersonMatthew L and Beth S PfeifferPfizer Foundation - MatchingGifts ProgramPharmacia Matching Gift -A Program of the Pfizer FdnPhilips PACE - Personal AccessCenter for EmployeesMichael and Mary PiascikJohn J Piecoro JrKerry P PierceMichael E and Carrie W PittScott W PlayleMary K PolumboChester P and Louise M PorembskiGary R and Debra T PolingRonald G and Diana S PolingLloyd E PorterRenita J PorterAndrew P PrestonProgressive Medical IncShawn A and Maria S PruchnickiWilliam H and Janice S PuckettAndrew J and Vanessa P PultzAnil RalhanJoyce S ReeseJoseph D and Judith S ReichertKarl A and Mary H RennerMichael V and Barbara RestainoMichael K and Tenna E RhonemusPeter J RiceJon P and Mary B RiegleCharles P RiffleJames D RiggsGeorge B RingsSteven W and Laura A RingsRite Aid Headquarters CorpChristine L RitzmanRobert E MatthewsFamily FoundationRobert T Webster Living TrustMartin S RobinsEdward B RocheRoche Matching Gifts ProgramJennifer L RodisEliezer Rodriguez-Cosme andJaninah S Barreto-HernandezLori C RogersDouglas W RoseBarbara M RossJames F RundoCurtis J RudeRobert R and Stephany B RuffoloJoshua and Belinda B RussellS & A RealtyShawn D SalkowL E SalserCynthia A SanoskiJohn M and Marylou Ebbert-SauerMarie E SaviniRobert M and Kathleen H SchaffnerDouglas J and Cheri M Hada-ScheckelhoffAriane K SchieberPaul L Schiff JrRalph and Tiffany A SchmittTodd and Toni M SchmittThomas D and Janet W SchmittgenJay W SchneiderRudolph SchorBill and Cheryl J SchottJudy B SchultzSchwieterman's Drug Store IncDavid A SchumannThomas E and Frances C SconoJill I SeckelMs Mary K SeegerKobi M SethnaJoseph R and Kathy N SeverinskiCorinne Shaevitz CovelShari L Shafron JacobsonSuzanne W SharpMs Sue N ShaunessyLaura M ShawThomas J SheaJeffrey T ShererDavid G ShipperTom SherrinBarry H ShickYangmee ShinDavid L ShonkSonya M ShultzSonya M Shultz TrustBruce E Sill and Linda W SillJames O Simmons Jr57

Michael W SillmanWarren E SinkhornStephanie A SinkovichKenneth A and Kathleen C SkauFadi R Smiley and Fatima A BarberDouglas F SmithGregory C SmithScott B Smith and Karen WetzFadi R Smiley and Fatima A BarberKevin J and Lori D SnyderKhristene SonDi Song and Juan WangRobert E and Beth K SparksJennifer S SpidleLouis P and Roberta W SposatoSara N St AngeloMary D StarkeyCarolyn L StangMichael B StebeltonMichael A SteeleBrian E and Andrea L StegerHoward S and Lenore H SternJames R StevensonJames A and Barbara E SterchelePaul and Suzanne C StivisonGerard A Stock JrCreg F StockwellRobert C StoutKurt A and Stacey S StricklerJo Ann S StubbingsJames H StewartLaura V StewartJorja K SturekMeghan M SullivanSara M SutherlandJason L and Lisa B SwartzLynn M SweeneyTodd A and Alicia A TackageGabriel and Susan G TannenbaumPaul T TavanoSai-Chiu M TangHarry and Cynthia P K TaubmanJames R TaylorThomas N TaylorWilliam J TaylorJoanne TaverasFrederick J and Beth A TheissBruce A ThomasDonald A ThompsonCarl F ThorntonChristopher U TicknorNicholas C TrauschDouglas W and Wanda F TremblayJoan M TrentJames P and Ellen J TresselMarcia R TriskaPete C and Gaylene S TsipisW K Van TyleTween Brands IncWilliam and Barbara T TzagournisUB Foundation Activities IncGreg S and Carlene M UmsteadThomas G UrchekG A VassVrable Health Care ServicesKathleen J ViesonMark A Villers andTricia D Smith-VillersRoger J VowellKristin W VitouDarko J Vodopich and Theresa J RuizJohn Vrontos JrJohn L and Maria I Papouras-VolakisPatricia G VornholtLaura A VothAmy M VyhnalekDaniel B and Rita F WaitzmanJeffrey A and Elizabeth W WallaceWilliam R WallaceLane J and Rhonda WallaceDavid L WantzMichael D and Carol T WarmuthWilbur J WardJames R and Ida A WarnerWhittie O and Jean M WeaverAlan K WebsterWellington R and Stephanie LPainter-WebbShannon WeiherJennifer L WeisburnKevin L WeissWellpoint Foundation AssociateGiving CampaignWells Living TrustBryan W and Jane B WengerJ B and Gloria P WengerBev G WestonCarl H and Jacquelin H WheelerPaul A Wherry *Whiston FoundationWHP-RX Consulting-Speaking LLCRoger L and Paula D WhiteJohn K and Mary J WhiteRobert R and Dianne S WhittenMark T Widman andKatherine A KelleyMichele G WillisJeffrey R WisemanClifford C WilliamsJames L and Jacquelyn L WilliamsJohn C and Linda C WilsonJean G WindesheimNorman A WinstonMark F Witcher and Margaret A BushWolters Kluwer HealthNancy T WoodWolfe Associates IncKaren H WootenDavid W and Paula B WorthWyeth Matching GiftsMamdoh S YaakobTerrence D YoderJohn C and Jane B YoungJacqueline A YoungRichard T and Kathryn M YowlerRuth A ZellmerDavid P ZgarrickTimothy M ZgoncJason T and Angela J ZielinskiMichael F and Jean A ZorkoRichard A and Heidi P Zoyhofski* Deceased58

Dean’s Corporate CouncilThe Dean’s Corporate Council under the leadership of chair, Mark Sirgo, continues to increase its engagementwith the College. The group focused on pharmacy practice and opportunities for students beyond the classroom.Presentations on the Doctor of Pharmacy program, Partners for Promotion, and our model with Kroger Food &Drug led to new sites with Wal-Mart and renewed interest in finding internships within members’ corporations.We successfully recruited key alumni and contacts from sectors that were lacking in representation on the Council.Dean’s Corporate Council, 2007Name Title Affiliation City, StateRussel R. Allinson, RPh, MS Principal Therigy, LLC Longwood, FLRoger W. Anderson, Dr.PH Senior Vice President Medco Health Solutions, Inc. Franklin Lakes, NJPamela Bernadella, RPh Manager Professional Target Pharmacy Minneapolis, MNServicesPaul Blower, PhD Chief Scientific Officer Leadscope Inc. Columbus, OHArne F. Brodin, PhD Director, Special Projects AstraZeneca SwedenEd Cohen, PharmD Director, Clinical Services Walgreens Health Initiative Deerfield, ILAndrew Dahlem, PhD Chief, Research Operations Eli Lilly Indianapolis, INBruce L. Downey Chairman and CEO Barr Laboratories, Inc. Woodcliff Lake,Arnie Fox Pharmacy Regional Manager Wal-Mart Stores, Inc. Bentonville, ARHarold N. Godwin, MS, RPh Professor, Chair, and University of Kansas Kansas City, KSAssociate Dean of Pharmacyfor Medical Ctr AffairsMaryann Kennedy Director, Medical Liaisons Roche Laboratories, Inc Nutley, NJStephen B. Krinke, RPh Director, Pharmacy Affairs Mylan Pharmaceuticals Inc Morgantown, WVandTrade DevelopmentJohn Long, MBA Senior Vice President Emdeon Twinsburg, OHJohn A. MacDonald Consultant Yarmouth Port, MARob Mains Vice President Cardinal Health, Inc. Stow, OHRobert E. Martini Retired Chairman AmerisourceBergen Corp Orange, CALarry Moore Retired American Red Cross Columbus, OHMichael A. Nameth Executive Vice President Medmark, Inc. Carnegie, PAMarcia I. Nusgart President Nusgart Consulting Bethesda, MDPatrick O’Neill, PhD Industry Advisor Avista Capital Holdings Doylestown, PARobert R. Ruffolo, Jr., PhD President, R&D Wyeth Collegeville, PASenior Vice PresidentWilliam F. Sheridan Pharmacy Merchandiser Kroger Food & Drug Westerville, OHMark A. Sirgo, PharmD President & CEO BioDelivery Sciences Intl Morrisville, NCCouncil ChairJames Staker Retired Staker Drugs Portsmouth, OhioAllan K. Vrable Owner Vrable Healthcare Powell, OHMary Ann Wagner Vice President NACDS Alexandria, VAJinn Wu, PhD President XenoBiotic Laboratories Inc Plainsboro, NJ59

Financial ReportThe financial outlook for the College of Pharmacy remainspositive. The decreased funds available from state instructionalsupport for higher education are counterbalanced by revenues fromincreases in student enrollment, tuition, extramural researchfunding, and development. The collegeexpects steady growth over thecoming years as enrollment,tuition, and statesupport stabilize.Gail Vornholt is well-known inour College. You can find herdressed in Buckeye colorsencouraging all of us to supportour university AND ourcommunity. As Human ResourceAdministrator Gail is responsiblefor all faculty, staff and visitingscholar HR functions (hiring,performance evaluation,compensation issues, benefits,etc). Her welcoming andpersonable demeanor areimportant characteristics for ahuman resource manager as sheis often the link between anemployee and the sometimescumbersome universitybureaucracy.Most fall weekends you willfind Gail at Ohio Stadium as she isan avid Buckeye fan. But, if youcannot find Gail at the College, orat the Stadium, you might checkout the roulette wheel at PlanetHollywood in Las Vegas. Gail andher new husband, Ryan, spend asmuch of their free time aspossible in Las Vegas. “Vegas ismy beach!”, says Gail. She andRyan were married in a smallchapel at the Aladdin ResortCasino now known as PlanetHollywood Resort and Casino inVegas just three years ago.Gail has been at OSU for twelveyears, Radiology (Hospital) for tenyears and College of Pharmacyfor three. The smaller and moreintimate environment inPharmacy appeals to her moresocial personality.more text tocome?60

Vision and Mission StatementsOur Mission:The overall mission of the College of Pharmacy is to improvemedications and medication-related health outcomes for thepeople of Ohio and the global community through our teaching,through our research and through our service. The College willprovide high quality education in the pharmaceutical sciencesand pharmacy practice to professional, undergraduate, graduateand postgraduate students through teaching, research, practiceand related service activitys including outreach and engagement.Our Core Values:We value innovation, teaching, learning and the advancementand sharing of knowledge.We value research and its application toward improving the use ofmedications in society.We value patient-centered pharmacy services and professionalism.We value our students, faculty, staff, alumni and friends.We value diversity in all of its forms.Our Overarching Goal:The Ohio State University College of Pharmacy will be amongthe world’s truly great institutions of pharmacy education.

In “Block O” formation, student leaders 2007-2008: Patrick Owcarz, Taylor Bentley, Kristin Filicky, Issifu Tenii, Megan Harns, AndreaReynolds, Brittany Lincoln, Jillian Elliott, Josh Close, Laura Connell, Negin Soufi, Lindsey CorbettNonprofit Org.U.S. PostageP A I DColumbus, OhioPermit No. 711The Ohio State UniversityCollege of Pharmacy500 West 12th AvenueColumbus,Ohio 43210-1291